Malignant neoplasm of digestive organs

C3_DIGESTIVE_ORGANS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_OESOPHAGUS C3_STOMACH C3_SMALL_INTESTINE C3_COLON C3_RECTOSIGMOID_JUNCTION C3_RECTUM C3_ANUS_ANALCANAL C3_BILIARY_GALLBLADDER C3_PANCREAS C3_DIGESTIVE_ORGANS_NAS	17405
6. Filter based on genotype QC (FinnGen only)	17405

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_DIGESTIVE_ORGANS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_OESOPHAGUS\|C3_STOMACH\|C3_SMALL_INTESTINE\|C3_COLON\|C3_RECTOSIGMOID_JUNCTION\|C3_RECTUM\|C3_ANUS_ANALCANAL\|C3_BILIARY_GALLBLADDER\|C3_PANCREAS\|C3_DIGESTIVE_ORGANS_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of digestive organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	17405	6851	10554
Unadjusted period prevalence (%)	3.74	2.34	4.65
Median age at first event (years)	69.05	67.72	69.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15985: Matched controls
157035

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z51.5

ICD-10 Finland

Palliative care

7.0

323.0

2861

4732

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

1737.2

323.0

2887

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

157.2

323.0

1227

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

145.6

323.0

722

TPH07

NOMESCO Finland

Cathetrisation of artery

3.6

323.0

2947

9259

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

149.5

323.0

615

WX600

NOMESCO Finland

Single shot through catheter

21.2

323.0

632

304

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

87.9

323.0

367

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

15.8

323.0

2831

2114

WZC30

NOMESCO Finland

Teaching

3.8

323.0

3559

10885

JAH00

NOMESCO Finland

Laparotomy

7.1

323.0

1049

1541

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

323.0

1847

5998

JAH01

NOMESCO Finland

Laparoscopy

5.7

323.0

1046

1910

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

29.9

323.0

1917

711

130

Kela drug reimbursment

Malignant tumour

33.4

323.0

8137

4731

JN4BD

NOMESCO Finland

Extensive body CT

7.4

323.0

4982

9032

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

243.6

323.0

340

UJF32

NOMESCO Finland

Coloscopy

4.6

323.0

7684

26237

JFB30

NOMESCO Finland

Right hemicolectomy

40.0

323.0

1318

352

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

12.3

323.0

945

801

JG1CG

NOMESCO Finland

Extensive MRI of rectum

96.4

323.0

513

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

241.7

323.0

1036

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

40.8

323.0

729

184

R4190

NOMESCO Finland

Nutritional therapy

7.6

323.0

968

1324

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

7800.6

323.0

767

B01AB05

ATC

enoxaparin; parenteral

3.3

323.0

7343

32393

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

617.5

323.0

489

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

5835.5

323.0

583

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

154.6

323.0

606

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

104.5

323.0

789

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

12.3

323.0

1388

1207

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

55.7

323.0

1159

220

JN4CD

NOMESCO Finland

Very extensive body CT

7.8

323.0

1803

2523

A09AA02

ATC

multienzymes (lipase, protease etc.)

10.8

323.0

949

911

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.4

323.0

3369

6257

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

8.7

323.0

1774

2227

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

6.0

323.0

1270

2215

TPX10

NOMESCO Finland

Implantation of vascular injection port

8.1

323.0

1198

1556

JLC30

NOMESCO Finland

Pancreatoduodenectomy

59.2

323.0

480

JFB00

NOMESCO Finland

Partial resection of small intestine

9.9

323.0

742

767

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.8

323.0

2887

8695

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

112.2

323.0

509

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

145.9

323.0

1806

137

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

182.0

323.0

380

JG1BG

NOMESCO Finland

MRI of rectum

120.2

323.0

635

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

15.5

323.0

557

364

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

1833.3

323.0

683

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

307.1

323.0

334

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

323.0

5606

25873

WX402

NOMESCO Finland

General anaesthesia

2.6

323.0

2927

12268

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

24.1

323.0

553

233

N02AA05

ATC

oxycodone; systemic

3.9

323.0

4670

14995

K83.1

ICD-10 Finland

Obstruction of bile duct

12.7

323.0

655

528

JFF23

NOMESCO Finland

Transversostomy

35.5

323.0

879

257

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

11.2

323.0

1822

1781

L01BC06

ATC

capecitabine; oral

161.6

323.0

4658

399

B01AB10

ATC

tinzaparin; parenteral

4.2

323.0

1954

5009

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

19.2

323.0

562

297

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

1102.9

323.0

543

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

4164.7

323.0

423

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

323.0

503

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

16.3

323.0

793

501

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

76.1

323.0

696

A03FA01

ATC

metoclopramide; systemic, rectal

7.7

323.0

7711

17012

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

223.6

323.0

676

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

1835.1

323.0

348

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

272.0

323.0

913

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

323.0

478

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4999.0

323.0

1426

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

231.6

323.0

3208

170

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

126.1

323.0

747

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

10.9

323.0

1002

956

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

12.9

323.0

679

537

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

46.5

323.0

416

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

75.3

323.0

975

135

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

187.9

323.0

392

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

323.0

1944

4315

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

323.0

5928

31123

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

42.6

323.0

747

180

WF001

NOMESCO Finland

Preoperative radiotherapy

100.3

323.0

933

TJF80

NOMESCO Finland

Ostomy education

21.5

323.0

591

280

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

102.5

323.0

1295

135

JN4AD

NOMESCO Finland

Body CT examination

5.7

323.0

2979

6051

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

253.6

323.0

378

Z93.3

ICD-10 Finland

Colostomy status

31.7

323.0

570

183

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

16.6

323.0

535

326

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

7.4

323.0

2032

3045

A04AA01

ATC

ondansetron; systemic, rectal

5.1

323.0

1961

4225

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

335.9

323.0

1673

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

12.2

323.0

1116

961

C20

ICD-10 Finland

Malignant neoplasm of rectum

944.2

323.0

822

WX302

NOMESCO Finland

Thoracal epidural anesthesy

18.1

323.0

3532

2427

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

8.6

323.0

1245

1530

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

317.2

323.0

444

D75

ICPC

Malignant neoplasm colon/rectum

141.7

323.0

717

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

340.6

323.0

409

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

60.7

323.0

486

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.7

323.0

6265

30707

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

13.0

323.0

904

720

A04AA02

ATC

granisetron; systemic, transdermal

15.5

323.0

3700

2994

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

178.0

323.0

627

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.6

323.0

1535

3562

H02AB02

ATC

dexamethasone; systemic

7.3

323.0

4212

7342

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

8.1

323.0

2774

3968

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

11.6

323.0

1985

1892

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

13.7

323.0

879

666

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

275.2

319.4

328

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

9.9

315.1

662

681

ZX120

NOMESCO Finland

Intravenous

2.9

305.6

2112

7834

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

9.6

305.5

654

696

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

305.4

4045

21236

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

85.9

302.4

342

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

135.7

301.5

325

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.5

300.6

955

1800

UJK02

NOMESCO Finland

ERCP

6.0

300.5

883

1513

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

113.1

298.2

327

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

49.7

298.0

366

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

371.4

295.4

299

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

234.1

293.5

304

C16.00

ICD-10 Finland

Cardia

190.2

289.6

304

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

288.5

278

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

90.3

288.2

324

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

13.6

286.1

513

381

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

81.5

285.5

325

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.0

281.7

1809

6369

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

8.1

280.2

662

831

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

191.3

273.5

287

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

342.0

271.7

276

WW500

NOMESCO Finland

Blood transfusion

4.2

267.0

1107

2751

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

860.6

262.4

259

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

2447.9

262.2

255

JFF10

NOMESCO Finland

Loop enterostomy

28.2

262.1

365

130

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.3

261.5

570

625

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

167.3

253.0

268

UJG02

NOMESCO Finland

Proctoscopy

6.3

248.5

698

1124

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.8

246.9

555

641

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

75.8

243.6

280

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

30.5

243.5

332

109

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

47.8

243.5

301

D77

ICPC

Malignant digestive neopl other/NOS

47.8

243.5

301

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.2

243.4

695

1143

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.3

241.5

1318

4113

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

15.3

240.7

410

269

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

168.3

238.9

253

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.1

238.1

1017

2590

JFB43

NOMESCO Finland

Left hemicolectomy

19.2

237.4

372

195

XX3DW

NOMESCO Finland

Time consuming IT work

2.5

237.2

2071

8735

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

10.8

235.7

471

439

A02BC02

ATC

pantoprazole; systemic

1.7

234.7

10256

79542

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

7.9

231.9

557

716

JFB46

NOMESCO Finland

Resection of sigmoid colon

9.3

231.2

503

549

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

238.2

231.0

239

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.2

230.6

541

670

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

38.2

230.4

298

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.6

230.1

567

758

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

1124.7

230.0

226

L01BC59

ATC

trifluridine, combinations; systemic

1089.3

222.8

219

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.0

221.6

956

2453

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

440.0

220.7

222

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.8

220.2

787

1681

176

Kela drug reimbursment

Regorafenib

438.0

219.7

221

A04AA55

ATC

palonosetron, combinations; systemic

5.7

218.3

664

1181

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.1

218.1

627

1039

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

50.9

216.9

265

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

216.4

2386

11289

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

214.6

207

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

1048.9

214.5

211

369

Kela drug reimbursment

Regorafenib

423.8

212.5

214

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

1033.8

211.4

208

A04AD12

ATC

aprepitant; systemic

6.6

207.1

562

862

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

235.5

205.7

213

107

Kela drug reimbursment

Pernicious anaemia

5.1

205.1

693

1392

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

144.7

203.5

218

JJB10

NOMESCO Finland

Atypcal resection of liver

106.3

203.1

224

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

1854.2

200.9

196

ZX095

NOMESCO Finland

Combined chemoradiotherapy

16.2

200.0

333

206

H01CB03

ATC

lanreotide; parenteral

72.1

199.7

231

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

31.1

197.7

268

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

82.7

197.3

224

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.5

195.6

998

2942

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

193.0

2374

11753

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

22.5

192.7

286

127

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

188.8

5058

33163

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

153.8

188.6

201

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

103.5

188.1

208

R18

ICD-10 Finland

Ascites

5.8

186.5

558

971

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

26.9

184.0

259

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.7

183.9

491

736

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

183.6

1488

5968

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

183.4

177

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

172.6

180.8

191

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

121.8

180.2

196

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

260.4

177.8

183

E34.0

ICD-10 Finland

Carcinoid syndrome

61.1

176.5

209

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

10.9

176.4

351

324

A06AH03

ATC

naloxegol; oral

8.0

175.9

417

524

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

168.0

175.7

186

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

350.9

175.5

178

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

16.0

175.3

293

183

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.2

174.5

494

801

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

173.1

833

2338

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

1753.9

173.0

169

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

123.9

172.2

187

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

564.1

171.4

171

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

170.6

2956

16693

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

169.9

164

H01CB02

ATC

octreotide; parenteral

44.1

169.9

213

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

149.0

168.5

180

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

64.6

166.1

195

JKA20

NOMESCO Finland

Cholecystectomy

3.7

164.5

767

2095

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.2

162.5

531

1025

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

65.0

162.1

190

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

236.7

161.4

167

R50.9

ICD-10 Finland

Fever, unspecified

2.0

160.9

2332

12275

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

160.6

155

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

397.0

159.5

161

C18

ICD-10 Finland

Malignant neoplasm of colon

523.9

159.0

159

D76

ICPC

Malignant neoplasm pancreas

55.8

159.0

191

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

159.0

1352

5549

L03AA02

ATC

filgrastim; parenteral

4.1

156.1

645

1583

1XC07

NOMESCO Finland

45.9

156.0

194

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

155.1

2135

10995

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

179.7

154.8

163

L01BC53

ATC

tegafur, combinations; systemic

757.2

154.5

153

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

150.2

145

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

133.1

149.3

161

K56.7

ICD-10 Finland

Ileus, unspecified

5.0

147.4

503

1018

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

190.9

146.9

154

B01AB04

ATC

dalteparin; parenteral

2.8

146.5

1048

3885

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

146.1

141

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

145.8

2932

17312

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

36.3

145.6

190

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

144.8

1006

3660

L01XE21

ATC

[U] regorafenib; oral

473.7

143.6

144

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

143.3

1548

7156

A79

ICPC

Malignancy NOS

6.0

143.2

415

693

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

211.0

143.1

149

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

143.0

138

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.0

142.9

619

1584

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

141.5

921

3214

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

51.7

141.5

172

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

140.4

7102

53768

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

139.8

135

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

8.7

138.4

310

355

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

136.7

132

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

13.9

136.3

241

173

SPAT1125

SPAT

Stoma care and guidance

4.7

135.5

491

1059

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

93.6

135.2

151

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

79.4

133.4

152

K83.0

ICD-10 Finland

Cholangitis

5.6

131.6

406

732

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

192.4

129.9

136

R4110

NOMESCO Finland

Physiotherapy

1.6

129.7

4052

27117

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

62.8

129.1

152

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

24.3

128.7

186

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

5.0

127.8

437

886

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

126.4

122

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

125.0

866

3140

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.5

124.7

385

695

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

42.0

124.3

157

JDE00

NOMESCO Finland

Gastrojejunostomy

36.9

123.2

160

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.7

123.1

372

654

K92.1

ICD-10 Finland

Melaena

2.4

122.7

1123

4768

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

96.3

122.2

136

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

21.0

120.4

182

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

10.5

120.2

242

229

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

12.3

119.8

223

180

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

119.8

1683

8673

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

119.1

115

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

32.2

118.7

159

JMA10

NOMESCO Finland

Transabdominal total splenectomy

11.5

118.6

228

197

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

582.1

118.4

118

Z93

ICD-10 Finland

Artificial opening status

23.9

117.8

171

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

1136.6

117.1

115

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

1136.6

117.1

115

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

172.5

115.7

122

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

56.9

115.5

138

V03AF03

ATC

calcium folinate; systemic

36.3

115.1

150

198

Kela drug reimbursment

Sorafenib

27.1

114.9

161

J01MA12

ATC

levofloxacin; systemic

1.7

114.2

3157

20319

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

111.6

113.2

124

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

5.4

113.2

358

665

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.4

112.6

1024

4326

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

370.1

111.7

113

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

110.8

107

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

+∞

110.8

107

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

+∞

110.8

107

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

542.1

110.2

110

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

109.6

1041

4497

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

20.2

109.2

167

JLC10

NOMESCO Finland

Distal pancreatectomy

25.7

107.7

153

WX704

NOMESCO Finland

Intubation

2.3

107.4

1128

5116

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

6.8

106.9

281

412

JGB36

NOMESCO Finland

Wide excision of rectum

181.3

104.7

110

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

1017.1

104.7

103

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

179.6

103.7

109

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

343.4

103.5

105

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.8

103.5

728

2660

JJB30

NOMESCO Finland

Excision of two segments of liver

123.1

103.3

112

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

16.4

102.7

169

102

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

100.7

101.3

112

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

151.1

100.5

107

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

100.4

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

173.0

99.6

105

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

967.3

99.5

A06AD11

ATC

lactulose; oral

1.6

99.3

2718

17361

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

99.2

709

2615

JJB71

NOMESCO Finland

Laparoscopic resection of liver

203.6

98.8

103

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

42.3

98.5

124

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.6

98.1

468

1299

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

9.3

96.7

207

220

WF004

NOMESCO Finland

Palliative radiotherapy

3.6

96.6

464

1295

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

9.0

96.2

210

231

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

244.7

96.0

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

197.6

95.8

100

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

197.6

95.8

100

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

7.4

95.7

236

316

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

103.8

95.3

105

R11

ICD-10 Finland

Nausea and vomiting

2.1

95.2

1208

5947

L03AA13

ATC

pegfilgrastim; parenteral

2.9

94.6

619

2160

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

94.4

1018

4664

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

102.8

94.3

104

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.8

94.3

247

361

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

94.1

667

2447

N02AX02

ATC

tramadol; systemic, rectal

1.4

93.9

6359

49661

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

193.7

93.7

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

124.8

93.3

101

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.8

92.7

244

359

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

92.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

90.4

314

648

D74

ICPC

Malignant neoplasm stomach

84.1

90.4

102

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

90.8

90.3

101

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

867.8

89.2

Z31.5

ICD-10 Finland

Genetic counselling

3.1

89.0

527

1720

Z43.3

ICD-10 Finland

Attention to colostomy

22.4

88.7

131

C25

ICD-10 Finland

Malignant neoplasm of pancreas

134.1

88.4

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

22.0

88.2

131

JF2AB

NOMESCO Finland

Colongraphy with X-ray

18.5

87.7

138

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.8

87.3

599

2154

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

848.0

87.1

D99

ICPC

Disease digestive system other

5.9

87.1

255

432

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

46.0

86.4

107

WX002

NOMESCO Finland

Sedation and analgesia

1.6

86.2

2977

20092

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

838.0

86.1

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

5.7

86.1

259

454

TPX15

NOMESCO Finland

Removal of vascular injection port

10.3

86.0

174

167

JFB50

NOMESCO Finland

Other resection of colon

15.5

85.7

144

JFB40

NOMESCO Finland

Resection of transverse colon

26.0

85.7

121

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

422.4

85.5

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

149.8

85.5

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

6.0

85.0

245

407

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

8.1

84.7

197

241

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

148.1

84.5

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

84.3

760

3185

L01XE05

ATC

[U] sorafenib; oral

28.9

83.1

114

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.8

83.0

377

1004

SPAT1262

SPAT

Handing over of treatment supplies

1.6

82.8

2913

19721

E0000UV

ATC

1.4

82.4

5168

39493

C15.0

ICD-10 Finland

Malignant neoplasm: Cervical part of oesophagus

169.8

81.6

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

48.9

80.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

80.8

880

4045

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

20.5

80.4

122

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

79.7

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.8

79.7

535

1896

SPAT1109

SPAT

Analgesia with portable analgesic pump

7.1

78.4

198

275

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.0

78.1

483

1624

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

77.6

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

77.6

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

29.1

77.5

106

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

382.5

77.3

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.6

77.2

234

414

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

18.8

76.9

120

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

23.1

76.7

112

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

76.7

550

2029

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

19.0

76.5

119

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

78.2

76.5

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

134.9

76.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.5

76.1

369

1038

A98

ICPC

Health maint/preventive medicine

0.7

74.1

11651

124455

JFB20

NOMESCO Finland

Ileocaecal resection

9.0

73.7

161

178

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

82.0

73.4

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

362.6

73.2

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.0

73.2

188

268

Z93.2

ICD-10 Finland

Ileostomy status

13.2

73.1

131

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

73.0

469

1616

ZX121

NOMESCO Finland

Central venous catheter

12.1

73.0

136

111

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

26.5

72.8

102

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

187.5

72.6

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

72.5

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

98.7

72.3

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

689.1

70.6

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

70.4

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.0

70.4

236

470

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

30.3

70.2

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

32.8

70.1

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

10.5

69.5

139

131

JAL30

NOMESCO Finland

Omentectomy

5.3

69.4

219

407

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

69.3

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.6

69.3

168

220

Z43.2

ICD-10 Finland

Attention to ileostomy

20.6

67.5

102

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.0

67.4

416

1397

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

43.6

67.4

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

226.8

66.8

JJB20

NOMESCO Finland

Excision of single segment of liver

226.8

66.8

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

66.2

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

223.5

65.8

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

138.1

65.4

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

65.2

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

65.2

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

115.1

64.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

64.3

449

1630

UJF34

NOMESCO Finland

Left colonoscopy

5.8

63.9

187

318

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

79.0

63.5

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

619.6

63.4

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.5

62.8

230

503

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

609.7

62.4

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

62.1

WX004

NOMESCO Finland

Patient-controlled sedation

7.3

61.6

152

205

WF002

NOMESCO Finland

Radical radiotherapy

2.0

61.6

873

4471

JJA20

NOMESCO Finland

Open biopsy of liver

12.6

60.4

110

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

8.7

60.4

134

153

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

60.0

K65.0

ICD-10 Finland

Acute peritonitis

3.9

59.9

259

663

JN4DD

NOMESCO Finland

Scout CT scan of torso

20.7

59.7

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.1

59.5

194

375

D18

ICPC

Change in faeces/bowel movements

3.0

59.4

368

1239

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.2

59.1

330

1034

N02BE01

ATC

paracetamol; systemic, rectal

1.4

59.1

12493

113415

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

59.0

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

31.2

58.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

58.9

1130

6432

WX882

NOMESCO Finland

High dependency care

2.5

58.7

471

1855

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

58.5

879

4598

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

58.0

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.4

57.8

219

496

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.4

57.6

288

831

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

560.1

57.3

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

56.9

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

56.9

8480/3-C16.9

ICD-O-3

Mucinous adenocarcinoma of stomach, NOS

+∞

56.9

C24.09

ICD-10 Finland

Biliary duct or passage NOS

65.0

56.7

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

193.8

56.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

56.3

281

810

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

55.9

C24.02

ICD-10 Finland

Common bile duct

282.6

55.8

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

13.2

55.5

C24.00

ICD-10 Finland

Hepatic duct

118.3

55.4

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

29.6

55.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.8

55.2

378

1358

6404

FHL

Hemicolectomy on the right

19.7

55.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

10.0

54.3

111

110

JFF26

NOMESCO Finland

Sigmoidostomy

17.2

54.2

L01BC04

ATC

carmofur; oral

57.4

54.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.7

53.9

249

675

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

53.8

1377

8521

C16.21

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

272.3

53.8

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

21.3

53.7

WX892

NOMESCO Finland

Monitored bed care

1.7

52.9

1151

6801

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

15.2

52.9

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

180.7

52.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

52.4

585

2713

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

5.6

52.1

157

278

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.5

51.6

256

735

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

6.6

51.6

137

206

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

72.8

51.6

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

177.4

51.5

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

51.1

244

680

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

13.5

50.9

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

7.7

50.9

121

155

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

50.9

542

2462

8145/3-C16.0

ICD-O-3

Carcinoma, diffuse type of cardia, NOS

+∞

50.7

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

+∞

50.7

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

15.0

50.3

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

63.5

49.8

8070/3-C15.5

ICD-O-3

Squamous cell carcinoma, NOS, of lower third of esophagus

+∞

49.7

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

49.7

JFF13

NOMESCO Finland

Terminal enterostomy

12.5

49.3

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.6

48.9

370

1408

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

48.8

638

3160

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

48.6

8249/3-C17.2

ICD-O-3

Neuroendocrine tumor, grade 2 of ileum

+∞

48.6

UJD02

NOMESCO Finland

Gastroscopy

1.9

48.4

751

3970

6434

FHL

Anterior resection

14.1

48.0

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

9.0

47.7

103

113

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

47.6

1074

6408

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

47.6

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

47.6

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

47.6

P01AB01

ATC

metronidazole; oral, rectal

1.3

47.5

4707

37877

TJA10

NOMESCO Finland

Laparocentesis

10.1

47.3

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

11.1

47.1

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

13.4

47.0

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

46.6

8140/3-C16.3

ICD-O-3

Adenocarcinoma, NOS, of gastric antrum

+∞

46.6

JFF24

NOMESCO Finland

Laparoscopic transversostomy

29.6

46.6

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

160.9

46.5

JFC00

NOMESCO Finland

Entero-enterostomy

15.5

46.3

1XC08

NOMESCO Finland

451.0

46.0

C15.2

ICD-10 Finland

Malignant neoplasm: Abdominal part of oesophagus

231.4

45.6

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

45.5

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

45.5

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.5

45.5

381

1537

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

49.3

45.3

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

10.7

45.3

6322

FHL

Gastrectomy (including Roux-Y)

53.2

45.1

JFC10

NOMESCO Finland

Ileotransversostomy

31.1

44.9

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

3.0

44.5

270

898

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

44.5

309

1120

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

44.5

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

44.5

JEA00

NOMESCO Finland

Appendectomy

1.9

44.4

706

3767

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

44.3

2242

16146

1CD01

NOMESCO Finland

10.6

44.1

K92.0

ICD-10 Finland

Haematemesis

2.3

44.1

429

1865

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

28.2

43.8

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

43.5

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

+∞

43.5

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

43.5

C16.5

ICD-10 Finland

Malignant neoplasm: Lesser curvature of stomach, unspecified

151.0

43.5

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

151.0

43.5

323

Kela drug reimbursment

Sorafenib

25.0

43.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

42.8

1885

13203

C10AA07

ATC

rosuvastatin; oral

0.7

42.6

2042

26544

8145/3-C16.3

ICD-O-3

Carcinoma, diffuse type of gastric antrum

+∞

42.4

C16.31

ICD-10 Finland

Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma

+∞

42.4

8144/3-C16.2

ICD-O-3

Adenocarcinoma, intestinal type of body of stomach

+∞

42.4

C10AA05

ATC

atorvastatin; oral

0.8

42.2

4274

50184

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

54.7

42.0

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

5.5

42.0

128

231

K56.0

ICD-10 Finland

Paralytic ileus

3.4

41.9

207

595

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

6.2

41.5

115

184

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

144.4

41.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

41.4

493

2350

JFF00

NOMESCO Finland

Catheter enterostomy

30.1

40.9

M25.5

ICD-10 Finland

Pain in joint

0.7

40.8

1855

24334

T73

ICPC

Neoplasm endocrine other/unspecified

18.8

40.8

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

16.3

40.6

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

75.6

40.5

6435

FHL

Abdominoperineal resection and colostomy

57.9

39.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.5

39.4

192

546

8144/3-C16.3

ICD-O-3

Adenocarcinoma, intestinal type of gastric antrum

+∞

39.3

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

39.3

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

7.1

39.3

136

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

40.2

39.0

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

8.4

38.9

102

N03AX16

ATC

pregabalin; oral

1.3

38.8

2984

23010

C16.02

ICD-10 Finland

Malignant tumor of cardiac early intestinal gastric carcinoma

381.6

38.8

N02AA01

ATC

morphine; systemic, rectal

2.8

38.7

258

914

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

4.6

38.6

138

297

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

10.6

38.6

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

12.1

38.5

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

46.3

38.4

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

11.6

38.4

R03AC02

ATC

salbutamol; inhalant

0.8

38.3

4864

55820

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

38.3

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

38.3

SPAT1053

SPAT

Memory test

0.7

38.2

1473

19865

3AC01

NOMESCO Finland

3.5

38.2

182

509

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

38.2

1006

6255

K22.2

ICD-10 Finland

Oesophageal obstruction

3.3

38.0

195

577

SPAT1255

SPAT

Intravenous administration of medicine

1.7

38.0

921

5599

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

55.4

37.9

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

7.8

37.9

113

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

371.7

37.8

WW200

SPAT

0.5

37.6

410

7264

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

101.0

37.4

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

37.2

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

+∞

37.2

JFF30

NOMESCO Finland

Other colostomy

17.9

37.0

L01EX05

ATC

regorafenib; oral

361.8

36.7

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1235

1213

10.71

307.65

6.0

2.3

nmol/l

14.4

5.0

1.39

1216

1176

(4035726)

3863

11286

4.04

307.65

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

7889

43815

2.41

307.65

3.5

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9947

63010

2.29

307.65

5.8

4.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6180

33480

2.27

307.65

3.2

2.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7784

43404

2.38

307.65

3.7

2.5

u/l

56.0

60.0

5.32

7415

39708

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4572

23603

2.23

307.65

5.1

3.0

mmol/l

0.8

36.09

4369

21733

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11643

72846

2.73

307.65

16.7

5.5

umol/l

14.6

11.9

23.44

11359

68744

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1286

3865

3.46

307.65

1.5

1.4

ug/g

198.7

272.6

28.98

816

2319

(3013650) Neutrophils [#/volume] in Blood by Automated count

10645

76419

1.96

307.65

17.9

8.2

e9/l

4.1

4.3

13.50

9738

65795

(40768441) Liver Pathology biopsy report

635

663

9.75

307.65

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

2521

2235

12.81

307.65

5.4

2.1

u/ml

1217.2

641.5

0.94

2332

2012

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4093

14817

3.25

307.65

4.6

2.5

umol/l

17.5

8.4

33.55

3762

12820

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4545

12269

4.58

307.65

3.2

2.0

g/l

0.2

6.05

4355

11199

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1175

1348

9.13

307.65

3.4

2.1

u/ml

2064.0

266.2

1.43

1164

1316

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

10497

12129

19.95

307.65

8.2

2.2

ug/l

39.0

16.8

4.56

9614

9587

(3014576) Chloride [Moles/volume] in Serum or Plasma

3883

19328

2.26

307.65

9.3

6.5

mmol/l

104.7

104.4

3.55

3826

18856

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6598

40523

1.97

307.65

5.9

3.0

u/l

44.1

35.3

5.21

6358

37987

(3022145) Colonoscopy Study observation

4243

13711

3.71

307.65

1.5

1.3

—

(3032080) INR in Blood by Coagulation assay

9687

63217

2.15

307.65

10.4

10.8

inr

1.3

1.4

11.88

2552

17229

(3023368) Bacteria identified in Blood by Culture

7382

43638

2.15

307.65

5.6

4.3

—

(3033658) Prothrombin time (PT) actual/Normal

6252

34882

2.19

307.65

6.6

3.9

84.9

85.0

0.04

6164

34034

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

4150

3899

13.44

307.65

5.8

2.1

u/ml

4692.4

313.9

2.29

3768

3227

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3059

12068

2.81

307.65

3.8

2.3

u/l

48.1

51.0

0.09

2817

10184

(3024561) Albumin [Mass/volume] in Serum or Plasma

10601

63067

2.67

307.65

10.9

4.3

g/l

32.6

34.8

252.57

10222

57738

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

823

626

13.53

307.65

6.4

1.9

nmol/l

208.0

107.3

5.27

816

617

(3021162) Amylase [Enzymatic activity/volume] in Specimen

256

153

16.70

303.05

2.8

2.5

u/l

1227.3

1529.4

0.15

226

140

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4736

27742

1.93

293.65

8.7

2.7

mmol/l

2.5

26.01

4446

23813

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2402

10974

2.34

286.23

1.7

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3770

20977

1.98

268.33

2.3

2.7

19.2

22.0

25.27

3304

17545

(3022948) Iron [Moles/volume] in Serum or Plasma

4159

24016

1.93

264.89

2.3

2.6

umol/l

10.9

12.3

26.45

3942

21939

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3926

22302

1.95

262.23

2.3

2.6

g/l

2.4

2.2

26.98

3725

20379

(40768804) Tissue Pathology biopsy report

7532

52552

1.72

252.34

2.8

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1470

5746

2.66

243.14

2.6

2.8

u/ml

0.3

0.4

6.57

842

3268

(3015377) Calcium [Moles/volume] in Serum or Plasma

7022

48465

1.71

241.56

7.9

3.1

mmol/l

2.3

2.4

19.34

6478

40991

(3020779) Urea [Moles/volume] in Serum or Plasma

2736

14159

2.07

235.25

6.2

6.8

mmol/l

9.0

11.3

48.73

2601

13279

(40768797) Stomach Pathology biopsy report

3248

18299

1.92

217.35

1.6

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

522

1199

4.39

201.72

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12822

106294

1.71

200.40

18.1

7.2

u/l

112.0

78.8

201.81

12443

99243

(3013826) Glucose [Moles/volume] in Serum or Plasma

10629

84374

1.62

193.00

7.0

4.8

mmol/l

7.1

6.9

14.38

10256

79283

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5615

38209

1.66

192.15

2.4

2.3

mg/l

3.8

3.0

50.27

4884

32215

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11091

126953

0.61

190.18

4.2

4.8

mmol/l

4.4

4.5

4.81

9848

115165

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10970

125745

0.62

186.78

4.2

4.7

mmol/l

1.4

4.91

9655

113196

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11500

130344

0.61

186.13

4.6

5.4

mmol/l

2.5

2.6

6.08

10123

117735

(40758558) Short blood count panel - Blood

5048

33651

1.67

185.75

13.8

6.3

—

(3042936) Bacteria identified in Isolate by Culture

3429

20544

1.80

185.21

2.2

2.0

—

(3037121) Protein [Mass/volume] in Urine

1225

4990

2.52

184.58

5.5

2.7

g/l

0.2

0.3

3.67

893

1966

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1732

8346

2.16

176.39

9.7

9.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8789

67578

1.57

175.23

7.8

6.0

mmol/l

1.2

49.62

8226

60409

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9497

74362

1.57

174.33

8.7

6.7

mmol/l

1.2

51.86

7964

62108

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

164

124

13.13

170.66

3.6

2.2

pmol/l

84.7

69.7

0.30

134

117

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3291

19933

1.77

169.50

5.2

5.7

mmol/l

1.0

5.90

3091

18271

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2637

14937

1.87

169.37

8.8

7.4

g/l

115.3

120.9

41.95

2550

14387

(3003694) ABO and Rh group [Type] in Blood

4813

32375

1.64

167.54

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

2805

16578

1.79

155.66

8.4

7.0

96.4

95.3

17.16

2709

15893

(3023183) Ammonium ion [Moles/volume] in Plasma

818

2961

2.80

155.53

3.0

2.3

umol/l

37.3

33.1

3.93

673

2448

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

205

248

8.22

153.47

2.8

1.9

—

(3003396) Base excess in Arterial blood by calculation

3000

18492

1.72

142.40

8.1

6.7

mmol/l

0.9

1.1

2.18

2451

14344

(3027801) Oxygen [Partial pressure] in Arterial blood

2995

18475

1.72

141.71

8.2

6.6

kpa

13.5

11.8

50.21

2869

17482

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2995

18487

1.72

141.33

8.2

6.7

kpa

5.1

2.58

2875

17503

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10759

121652

0.66

140.31

3.8

4.2

mmol/l

1.3

4.55

9418

108444

(3002256) Pathology report gross observation

2902

17847

1.72

138.50

1.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10982

123248

0.67

132.45

6.7

6.5

mmol/mol

41.9

40.8

19.55

9870

111920

(3014111) Lactate [Moles/volume] in Serum or Plasma

2320

13725

1.77

126.00

6.9

6.4

mmol/l

1.4

0.19

2227

13158

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1343

6804

2.02

117.69

2.0

1.9

ug/l

2.2

2.3

0.16

1214

5878

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11605

127968

0.68

116.32

4.7

5.1

mmol/l

6.2

6.1

23.79

10318

114165

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

593

2120

2.81

115.07

2.3

1.8

ug/l

19.5

24.4

2.73

579

2063

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

466

1490

3.14

110.34

1.2

1.1

g/l

1.7

1.5

7.00

438

1314

(3026782) Osmolality of Urine

4251

30117

1.51

109.18

3.1

2.9

mosm/kgh2o

545.1

553.1

1.62

3784

25519

(3000991) Gas panel - Venous blood

2153

13025

1.72

106.67

8.1

7.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

828

3650

2.29

103.34

2.4

2.3

g/l

3.5

3.7

1.57

803

3468

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1588

9012

1.81

97.82

6.8

6.7

mmol/l

24.6

24.8

0.74

1574

8911

(3023487) Leukocytes [#/volume] in Peritoneal fluid

225

470

4.76

97.78

1.7

2.1

e6/l

5352.2

3658.7

0.19

164

328

(3018418) pH of Serum or Plasma

5761

44061

1.43

97.44

5.3

4.1

7.4

0.44

1309

8256

(3002582) Erythrocytes [#/volume] in Urine

5942

45773

1.42

96.24

3.6

3.5

e6/l

66.8

117.8

3.31

4879

35470

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6743

53198

1.40

94.84

3.0

2.9

ug/l

154.8

163.6

0.95

6215

48023

(42870588) Differential panel, method unspecified - Blood

6073

47089

1.41

94.24

5.3

5.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3414

23716

1.52

94.10

2.1

2.0

30.4

30.1

1.30

3342

22968

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10724

118579

0.71

93.51

4.3

4.7

mu/l

2.4

2.2

0.42

9402

106068

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1690

9899

1.75

93.24

9.3

8.4

0.7

3.92

1682

9817

(3010370) Gastrin [Moles/volume] in Serum or Plasma

128

163

7.78

91.85

2.6

1.4

pmol/l

76.0

42.6

1.44

107

132

(3033799) Differential panel - Peritoneal fluid

201

418

4.78

87.85

1.8

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

947

4718

2.03

86.24

1.3

—

(3039000) Anion gap in Blood

755

3452

2.20

86.07

8.8

6.6

mmol/l

11.0

11.3

1.55

679

3098

(3018572) Chloride [Moles/volume] in Blood

755

3453

2.20

86.01

8.8

6.6

mmol/l

106.1

104.9

10.41

679

3099

(3019069) Monocytes/100 leukocytes in Blood

7705

62868

1.37

85.25

5.8

6.3

9.1

8.9

4.40

7219

58155

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1662

9940

1.71

84.69

9.3

8.2

1.3

1.4

2.27

1653

9857

(3006504) Eosinophils/100 leukocytes in Blood

7663

62523

1.37

84.55

5.6

5.9

2.6

2.9

18.98

7180

57636

(3007566) Smooth muscle Ab [Titer] in Serum

686

3061

2.26

82.97

1.3

1.2

titre

70.0

158.0

2.76

260

(3002030) Lymphocytes/100 leukocytes in Blood

7815

64086

1.36

82.90

5.8

6.1

23.1

26.3

101.38

7273

58877

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2499

35090

0.65

82.05

1.7

1.6

mmol/l

1.4

1.3

4.07

2089

28815

(3022096) Basophils/100 leukocytes in Blood

7463

60827

1.36

81.99

5.7

6.0

0.6

0.7

20.41

6982

56127

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

194

415

4.64

81.96

1.7

1.9

e6/l

10943.3

13822.0

0.18

122

226

(3030467) Casts [#/volume] in Urine by Automated count

5392

41920

1.39

78.64

3.5

3.4

e6/l

0.7

0.5

3.33

4370

31891

(3047181) Lactate [Moles/volume] in Blood

935

4805

1.97

77.83

7.9

5.8

mmol/l

1.4

1.3

2.03

823

4251

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

750

3558

2.12

77.77

2.2

2.1

81.7

89.1

12.61

733

3327

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

950

4926

1.95

77.03

2.6

3.9

u/ml

90.6

75.1

0.66

918

4720

(3034770) Mitochondria Ab [Titer] in Serum

670

3052

2.21

77.00

1.3

1.2

titre

332.2

906.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1666

10222

1.67

76.75

8.7

6.8

mmol/l

24.5

24.6

0.23

1570

9521

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8550

96715

0.74

76.21

3.7

3.9

pmol/l

15.0

1.11

7511

85898

(36304419) Bacteria [Presence] in Urine

5161

40034

1.38

75.61

3.5

3.3

—

(3019060) Gas panel - Arterial blood

1742

10998

1.62

71.39

6.3

4.5

—

(3018010) Neutrophils/100 leukocytes in Blood

7606

63063

1.33

70.72

5.6

5.9

60.8

58.5

44.32

7118

58230

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

686

3279

2.10

69.67

2.2

2.3

222.2

202.5

6.20

657

3093

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

494

2064

2.40

69.53

6.0

6.1

mg/l

11.9

12.1

0.54

442

1867

(3000850) Epithelial cells [#/volume] in Urine

4218

32191

1.38

66.51

2.8

2.7

e6/l

5.6

4.6

4.82

3789

28108

(3025941) Bacteria identified in Stool by Culture

1151

6636

1.76

66.25

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

848

4465

1.91

65.51

1.8

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

193

492

3.89

64.88

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1154

6706

1.74

64.56

6.9

4.8

1.6

0.04

1070

6302

(3006315) Basophils [#/volume] in Blood

7946

66836

1.31

64.42

5.4

5.7

e9/l

0.0

13.36

6814

56844

(3007930) Methemoglobin/Hemoglobin.total in Blood

1140

6611

1.75

64.23

7.0

4.9

0.9

2.06

1056

6206

(3044007) Cell count panel - Peritoneal fluid

164

375

4.34

63.80

1.7

2.1

—

(3001604) Monocytes [#/volume] in Blood

7893

66436

1.31

63.20

5.4

5.6

e9/l

0.6

1.76

6767

56455

(3019198) Lymphocytes [#/volume] in Blood

8049

68094

1.30

61.36

5.5

5.7

e9/l

1.7

1.9

12.56

7030

58854

(3018095) Leukocytes [#/volume] in Urine

6310

51787

1.31

59.63

4.1

3.9

e6/l

133.0

116.9

0.48

5024

37787

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1457

9229

1.60

58.35

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1358

8477

1.63

57.73

9.5

8.4

mmol/l

24.0

24.3

2.70

1316

7784

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2605

18688

1.44

57.63

3.5

4.0

u/l

249.7

249.2

0.05

2477

17500

(3013115) Eosinophils [#/volume] in Blood

8091

68873

1.29

57.27

5.7

5.8

e9/l

0.2

21.98

7045

59359

(3013005) Retinol [Moles/volume] in Serum or Plasma

149

347

4.25

56.65

2.1

1.5

umol/l

1.9

2.1

1.03

140

325

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2157

15009

1.47

55.90

3.8

kpa

5.7

5.8

15.94

2088

14540

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9103

78826

1.29

55.69

4.7

3.1

u/l

107.4

52.5

103.55

8547

71593

(3002032) Base excess in Venous blood by calculation

2151

14998

1.47

55.11

3.8

mmol/l

1.9

0.24

1663

12184

(3012544) pH of Venous blood

2214

15566

1.46

54.27

3.8

7.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

9.56

51.66

2.0

1.6

ng/l

181.8

214.8

1.33

(3031040) Bacteria [#/volume] in Urine by Automated count

10445

92553

1.28

50.74

4.9

5.0

e6/l

2244.3

1318.5

0.68

173

1557

(4281824)

318

1255

2.52

50.70

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2623

19264

1.40

50.13

2.1

2.4

1.8

1.83

2334

16741

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2191

15617

1.44

49.56

5.1

3.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3190

24331

1.36

48.03

3.3

3.2

e6/l

2.7

2.1

2.29

1930

13530

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4156

49940

0.76

47.92

4.1

4.7

21.6

22.3

2.01

2052

26301

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1398

20101

0.66

47.78

1.2

1.3

iu/ml

48.1

38.9

1.09

440

6205

(1761868) Lipid panel - Serum or Plasma

3061

38299

0.74

46.85

3.0

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1564

10563

1.50

46.51

1.4

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

8.25

46.14

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1640

11207

1.49

46.01

1.4

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3397

26325

1.34

45.70

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1301

18779

0.66

45.07

1.2

u/ml

19.1

15.1

0.47

473

6581

(3018405) Lactate [Moles/volume] in Arterial blood

937

5671

1.66

44.74

5.0

4.0

mmol/l

1.4

0.15

922

5557

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

356

3.75

43.39

1.3

1.5

g/l

13.8

13.9

0.07

109

272

(3012501) Base excess in Blood by calculation

654

3619

1.81

43.02

4.7

4.2

mmol/l

2.8

2.6

1.20

477

2454

(3013290) Carbon dioxide [Partial pressure] in Blood

654

3621

1.81

42.94

4.7

4.2

kpa

5.0

0.19

642

3518

(3027315) Oxygen [Partial pressure] in Blood

655

3641

1.80

42.44

4.7

4.2

kpa

9.0

8.3

9.90

643

3537

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

522

3.19

41.93

3.0

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2860

35554

0.75

40.74

2.9

3.2

ug/l

0.8

1.02

1972

25272

(3010421) pH of Blood

716

4142

1.73

40.41

4.6

4.2

7.4

0.15

642

3521

(3036489) Thrombin time

783

4676

1.68

39.30

2.1

1.9

21.8

21.9

0.23

738

4161

(3026008) Bacteria identified in Urine by Culture

5470

45883

1.25

38.49

3.3

3.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1124

7366

1.54

38.28

3.9

4.1

mmol/l

23.9

24.1

1.18

1044

6583

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5496

62586

0.80

37.77

4.5

5.4

ug/l

3.1

4.2

3.59

4691

55514

(3010813) Leukocytes [#/volume] in Blood

13739

141889

0.78

37.22

46.2

24.3

e9/l

7.1

6.9

9.41

13380

136775

(3000963) Hemoglobin [Mass/volume] in Blood

13740

141887

0.78

37.09

46.5

24.5

g/l

124.5

134.1

307.65

13499

139147

(3026361) Erythrocytes [#/volume] in Blood

13739

141867

0.78

36.96

46.1

24.3

e12/l

4.2

4.4

307.65

13375

136695

(3024731) MCV [Entitic volume]

13739

141862

0.78

36.90

46.0

24.2

91.2

91.7

24.44

13506

139107

(3035941) MCH [Entitic mass]

13738

141850

0.78

36.87

45.9

24.2

30.1

30.5

99.33

13500

139099

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3958

46695

0.79

36.84

2.1

2.2

u/l

245.0

226.4

0.37

3706

43484

(3007461) Platelets [#/volume] in Blood

13736

141813

0.78

36.65

46.2

24.3

e9/l

250.3

240.1

44.20

13409

137258

(3051651) Icteric interference index of Serum or Plasma

221

859

2.55

36.50

5.6

3.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1734

12529

1.40

35.56

5.1

3.9

mmol/l

1.2

6.44

1596

10803

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

543

3019

1.79

35.17

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5756

64600

0.82

32.76

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

1689

12329

1.39

32.45

3.4

3.2

kpa

4.5

0.50

1623

11876

(3020891) Body temperature

968

6368

1.53

32.30

5.6

4.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

538

3166

1.69

28.55

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

350

1816

1.92

28.30

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

340

1756

1.92

27.88

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

341

1765

1.92

27.78

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

339

1759

1.91

27.42

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

338

1756

1.91

27.24

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

341

1782

1.90

27.00

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2313

18182

1.29

26.43

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2300

18160

1.28

25.30

1.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

102

323

3.12

24.86

1.2

1.4

g/l

40.6

43.9

0.05

256

(3004809) Band form neutrophils/100 leukocytes in Blood

446

2594

1.71

24.76

2.6

3.5

2.1

1.5

2.31

345

1988

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

123

4.57

24.07

2.0

58.5

64.3

0.49

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1157

8333

1.39

23.86

2.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3167

26141

1.24

23.59

3.2

3.0

e6/l

1.2

1.3

0.15

1894

15224

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

434

2556

1.69

23.03

5.6

4.9

iu/ml

746.8

1680.6

0.73

391

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

355

1977

1.78

22.99

1.4

1.5

pmol/l

150.0

214.0

1.35

348

1918

(3023520) Reticulocytes [#/volume] in Blood

1870

14564

1.30

22.73

2.2

2.5

e9/l

69.3

68.0

0.66

1448

11123

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13461

137894

0.83

22.67

38.3

19.6

umol/l

81.2

84.2

17.01

13450

137828

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

224

4274

0.51

22.51

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2114

16749

1.28

22.43

1.8

1.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

427

2526

1.68

22.29

3.0

3.3

e9/l

4.4

4.3

0.05

427

2518

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

9.49

21.89

1.6

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3403

38969

0.83

21.20

3.0

2.8

umol/l

4120.8

5716.7

1.42

2909

32899

(3017446) Testosterone [Moles/volume] in Serum or Plasma

767

10622

0.70

20.48

2.0

2.1

nmol/l

11.0

12.0

2.77

655

9139

(3014765) Yersinia sp identified in Stool by Organism specific culture

563

3639

1.54

20.39

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

559

3609

1.54

20.35

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

550

8063

0.66

19.85

2.3

2.4

au/ml

33.2

27.2

0.26

284

(42529406) Shigella sp [Presence] in Stool by Culture

561

3650

1.53

19.73

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

436

6707

0.63

19.73

1.8

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

680

4618

1.47

19.41

4.7

3.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

489

7265

0.65

18.83

1.2

1.3

au/ml

52.4

55.1

0.09

298

(3004119) Hemoglobin [Mass/volume] in Venous blood

1284

9777

1.32

18.32

3.4

g/l

120.2

127.8

27.54

1255

9528

(3027273) Bicarbonate [Moles/volume] in Venous blood

1086

8075

1.35

18.27

3.5

mmol/l

24.6

25.2

4.91

1048

7845

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13493

137624

0.84

18.13

21.2

10.8

u/l

28.5

25.4

29.65

13158

131471

(40761536) Microorganisms panel - Urine sediment

1472

11483

1.29

17.49

4.3

—

(3051611) Lipemic interference index of Serum or Plasma

283

1605

1.75

17.33

5.1

3.4

—

(1616796) Gas panel - Central venous blood

552

3691

1.49

17.07

3.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

700

4927

1.41

16.51

5.3

4.3

mmol/l

3.8

3.9

7.06

660

4598

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1009

7537

1.34

16.45

3.0

2.8

1.2

0.71

1000

7501

(3003338) MCHC [Mass/volume]

10026

104257

0.87

16.27

41.7

21.9

g/l

329.2

331.8

137.07

9908

103166

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1059

7983

1.33

16.21

1.4

1.6

g/l

1.7

1.6

3.53

908

6731

(1002224) Polysomnography panel

209

3674

0.55

16.09

1.1

—

(4010399)

771

10246

0.73

15.99

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

403

2556

1.56

15.97

2.0

1.9

mmol/l

1.8

1.7

0.93

398

2494

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

984

7368

1.33

15.78

2.9

2.7

0.7

3.21

959

7079

(3012516) Albumin [Mass/volume] in Urine

4156

45863

0.86

15.76

3.2

3.3

mg/l

387.0

405.0

0.10

2777

29420

(3006922) Hepatitis E virus Ab [Presence] in Serum

151

723

2.06

15.58

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

101

4.10

15.56

1.9

2.0

19.3

13.9

0.42

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

143

676

2.09

15.27

1.1

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

4.45

15.22

1.8

1.2

u/l

3355.7

204.9

0.85

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

143

677

2.09

15.22

1.1

1.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10193

94874

1.14

15.02

5.2

4.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

357

2238

1.58

14.91

2.8

2.5

—

(3019225) pH of Specimen

1890

15461

1.23

14.76

4.5

4.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3138

26909

1.18

14.76

4.4

4.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2745

23300

1.19

14.53

22.2

29.9

inr

1.4

1.5

3.80

426

3086

(3017181) Myelocytes/100 leukocytes in Blood

1501

12015

1.25

14.32

3.4

3.9

1.1

0.9

1.10

666

3582

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

407

2653

1.52

14.30

1.5

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

525

3609

1.45

14.15

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

238

2.82

14.09

3.4

4.4

u/l

54.3

57.1

0.04

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

525

3617

1.44

13.99

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

525

3618

1.44

13.97

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

970

12236

0.77

13.94

1.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4445

48441

0.87

13.74

4.0

mg/mmol

12.1

9.7

1.70

2876

30806

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

504

3461

1.45

13.67

1.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

316

1969

1.59

13.59

2.6

2.4

u/ml

2912.1

5158.6

0.21

137

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1413

11329

1.25

13.27

4.3

2.7

ml/min/173m2

63.1

60.2

2.05

612

4829

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

520

3616

1.43

13.19

4.5

2.8

mg/l

1.7

0.07

477

3235

(21494755) Public health laboratory ask at order entry panel

401

5762

0.68

13.10

1.2

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

196

1088

1.78

13.06

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

892

6768

1.31

13.05

1.9

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

286

1759

1.61

13.01

2.2

3.7

u/ml

20.7

39.9

6.05

273

1701

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.82

12.86

1.2

1.4

ml/s/173m2

1.4

0.8

2.70

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

192

1066

1.78

12.79

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

186

3162

0.57

12.77

1.4

1.7

mg/l

4.5

3.7

0.43

147

2280

(3021589) Normoblasts [#/volume] in Blood

6404

58294

1.13

12.57

16.6

10.2

e9/l

0.0

0.20

5227

47542

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11995

122539

0.88

12.45

31.1

15.8

ml/min/173m2

77.7

73.7

83.98

10844

101457

(3021879) Hepatitis B virus core Ab [Presence] in Serum

898

6871

1.30

12.36

1.2

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3700

32527

1.15

12.32

1.8

nmol/l

1197.0

1158.6

1.50

2865

24052

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

155

817

1.87

12.24

2.3

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

4288

46533

0.88

12.08

3.2

mmol/l

7.4

0.02

3461

38286

(3016244) Insulin [Units/volume] in Serum or Plasma

409

2.24

12.01

2.2

2.9

mu/l

13.8

26.6

4.38

386

(40767503) Oxygen content in Capillary blood by calculation

496

3483

1.41

11.95

2.6

15.0

16.0

4.72

209

1892

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

961

7460

1.28

11.84

4.1

4.2

48.6

47.0

1.33

953

7371

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

289

1824

1.57

11.83

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

643

4730

1.35

11.68

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

397

2.24

11.56

2.1

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

145

763

1.88

11.54

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

145

763

1.88

11.54

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1548

18150

0.82

11.54

4.1

4.9

32.9

0.00

993

11966

(3021440) Promyelocytes/100 leukocytes in Blood

1400

11402

1.23

11.34

3.5

4.0

0.1

0.21

612

3330

(40768795) Lymph node Pathology biopsy report

218

1308

1.65

11.03

1.2

—

(4094501)

237

3650

0.63

10.92

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

311

4516

0.67

10.80

1.1

1.2

u/ml

2.3

0.9

0.55

438

(3028308) Erythrocytes [#/volume] in Pleural fluid

322

2127

1.50

10.74

1.4

1.5

e6/l

77634.2

58336.5

0.32

206

1266

(3037522) Nuclear Ab [Titer] in Serum

1351

15939

0.82

10.71

1.3

titre

494.9

523.2

0.22

293

3504

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

380

2596

1.45

10.70

1.5

nmol/l

0.8

1.72

329

2136

(3023199) Leukocytes [#/volume] in Pleural fluid

346

2337

1.47

10.35

1.4

1.5

e6/l

1750.4

2532.3

0.77

259

1698

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

173

994

1.72

10.33

1.3

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

145

2.99

10.26

1.2

1.1

—

(3008898) HLA-B27 [Presence]

162

2685

0.59

10.19

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

805

6233

1.28

10.16

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1327

10870

1.22

10.15

3.2

3.8

0.8

0.7

0.79

459

2567

(3005322) IgE [Units/volume] in Serum or Plasma

486

6453

0.73

10.07

1.2

1.3

u/ml

201.7

247.1

0.86

434

5889

(3023103) Potassium [Moles/volume] in Serum or Plasma

13644

137794

0.88

10.01

35.9

19.9

mmol/l

4.0

47.07

13350

133850

(3000475) Leukocytes [#/volume] in Synovial fluid

254

3775

0.66

9.94

1.7

1.6

e6/l

15842.7

15170.2

0.08

182

2712

(3016650) Hepatitis A virus Ab [Presence] in Serum

270

1751

1.53

9.87

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

341

2.23

9.87

1.4

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1056

8484

1.24

9.74

3.1

2.9

e6/l

0.5

0.3

2.88

1045

8320

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

750

1.80

9.70

3.1

3.5

—

(3008037) Lactate [Moles/volume] in Venous blood

522

3831

1.35

9.69

3.6

3.5

mmol/l

1.8

1.6

1.24

514

3748

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

314

2112

1.47

9.63

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.05

9.60

3.8

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

264

1715

1.52

9.59

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

142

2390

0.58

9.51

1.6

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1054

0.38

9.34

1.0

ng/l

35.8

44.0

1.07

693

(3024471) HLA-A [Type]

343

2.19

9.33

1.0

—

(3024932) HLA-DR beta [Type]

331

2.21

9.29

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1051

0.38

9.28

1.0

ng/l

666.1

702.8

0.30

680

(3019550) Sodium [Moles/volume] in Serum or Plasma

13633

137551

0.89

9.26

35.9

19.8

mmol/l

138.9

139.6

190.76

13358

133819

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1047

0.38

9.20

1.0

ng/l

261.1

332.3

1.80

702

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

402

5418

0.72

9.19

1.2

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

377

2652

1.41

9.10

1.4

1.5

g/l

31.8

31.9

0.06

340

2369

(3045788) Cell count panel - Pleural fluid

268

1772

1.50

8.98

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

243

1576

1.52

8.93

2.7

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3405

30340

1.13

8.87

3.7

4.2

ng/l

396.5

488.6

0.43

2837

25812

(3038515) Glucose [Moles/volume] in Venous blood

495

3656

1.34

8.85

3.8

3.6

mmol/l

7.9

7.7

0.74

489

3582

(3048689) Calprotectin [Mass/mass] in Stool

1531

12887

1.19

8.73

1.9

2.1

ug/g

244.5

153.7

9.32

1216

9947

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

206

1298

1.57

8.64

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

282

1903

1.47

8.56

1.6

g/l

1.0

0.8

0.51

197

1415

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1379

11525

1.19

8.53

1.7

1.6

0.38

1167

9674

(40768806) Pleura Pathology biopsy report

299

2045

1.45

8.47

1.4

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

114

3.03

8.38

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

317

4371

0.71

8.37

1.6

—

(40768800) Prostate Pathology biopsy report

293

4087

0.70

8.28

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

282

1917

1.46

8.26

1.3

1.4

u/ml

103.5

120.2

1.88

437

(3010375) cycloSPORINE [Mass/volume] in Blood

100

525

1.88

8.17

31.4

27.1

ug/l

127.7

108.7

2.47

440

(3019832) Treponema pallidum Ab [Presence] in Serum

285

3982

0.70

8.14

1.4

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

212

3131

0.66

8.13

1.5

1.7

nmol/l

44.4

45.1

0.10

198

2988

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

522

3938

1.31

8.09

1.5

1.6

—

(3012441) Differential panel - Pleural fluid

296

2040

1.44

8.07

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

155

928

1.65

8.05

1.7

1.8

u/l

1857.8

1950.8

0.02

336

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

915

1.65

7.99

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

134

2176

0.60

7.88

1.1

1.2

u/ml

67.2

47.3

—

229

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

283

3932

0.70

7.84

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

311

2177

1.41

7.80

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6358

58925

1.10

7.72

3.9

4.2

ng/l

42.1

84.0

4.11

5121

44930

(40768443) Skin Pathology biopsy report

511

6479

0.77

7.70

1.2

—

(40761511) CBC panel - Blood by Automated count

13211

133205

0.90

7.67

29.9

15.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1189

13767

0.84

7.66

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

149

2.65

7.54

2.4

3.4

mg/l

1.5

1.1

0.50

118

(3019150) Specific gravity of Urine by Refractometry

2740

29806

0.89

7.43

4.3

4.5

kg/l

1.0

0.66

486

4659

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1730

14895

1.16

7.43

3.0

3.1

ng/l

221.5

253.9

2.25

1573

13665

(3009466) Valproate [Moles/volume] in Serum or Plasma

106

1789

0.58

7.29

3.5

4.2

umol/l

323.5

342.5

0.60

1479

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1693

18978

0.86

7.25

12.6

8.1

—

(3022475) Manganese [Moles/volume] in Blood

3.83

7.23

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

314

4220

0.73

7.15

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

179

1145

1.54

7.11

1.4

1.6

—

(3025159) Blasts/100 leukocytes in Blood

1261

10637

1.18

7.03

3.5

4.0

0.2

0.4

1.01

496

2810

(4034850)

340

4494

0.74

6.95

14.7

11.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

227

3205

0.69

6.94

1.1

1.2

u/ml

34.5

40.6

—

184

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

208

2983

0.68

6.93

1.7

—

(3042733) HLA Ab [Presence] in Serum

333

2.01

6.87

2.2

5.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

145

896

1.60

6.72

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

145

897

1.60

6.69

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

269

3664

0.72

6.69

1.5

1.7

—

(3003181) Sodium [Moles/volume] in Urine

380

2842

1.32

6.37

1.4

1.3

mmol/l

59.9

62.9

0.70

269

2289

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

312

2271

1.36

6.28

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

156

998

1.54

6.26

1.2

titre

92.0

140.7

1.39

184

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

156

998

1.54

6.26

1.2

titre

30.0

167.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

574

4538

1.25

6.24

5.0

4.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

401

1.87

6.22

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.24

6.22

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

181

2604

0.68

6.18

1.4

e6/l

276.8

2296.3

1.70

150

2133

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

181

2601

0.68

6.15

1.4

e6/l

19.4

28.0

0.42

145

2019

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

216

3004

0.70

6.12

1.1

1.3

u/ml

2.6

5.8

4.17

488

(3013512) EKG study

4818

44456

1.09

6.10

4.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

481

3735

1.28

6.09

3.7

2.9

kpa

8.1

7.9

1.24

443

3460

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

143

2.48

6.04

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

214

2968

0.71

5.98

1.1

1.3

u/ml

6.5

6.8

0.04

318

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

221

1533

1.42

5.95

1.1

1.2

u/l

71.9

60.8

0.57

161

993

(3022493) Free Hemoglobin [Mass/volume] in Plasma

104

611

1.68

5.94

2.6

4.2

mg/l

58.0

483.5

0.55

421

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1181

10053

1.17

5.91

1.8

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

451

1.79

5.90

37.0

32.0

ug/l

6.8

7.3

1.28

399

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

178

1188

1.48

5.87

1.3

1.2

nmol/l

1.3

1.4

0.35

157

1074

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

130

811

1.58

5.85

1.1

1.0

mg/l

303.5

286.5

1.41

115

724

(3013707) Erythrocyte sedimentation rate by Westergren method

9764

99339

0.93

5.83

3.8

4.3

mm/h

18.1

14.0

78.63

8824

90684

(3021788) Differential panel - Synovial fluid

201

2800

0.70

5.77

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

731

1.61

5.72

1.3

nmol/l

1.0

1.2

1.14

550

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

141

902

1.54

5.70

1.5

1.6

u/l

6.2

6.5

0.07

421

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

187

2628

0.70

5.66

1.3

u/l

43.7

39.0

0.27

161

2258

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

188

2627

0.70

5.52

1.2

1.3

mmol/l

3.9

0.03

178

2456

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

1052

1.49

5.51

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

117

728

1.59

5.36

1.2

u/l

260.8

360.7

0.73

108

669

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

159

2276

0.68

5.35

1.6

1.8

pmol/l

192.0

193.8

0.09

150

2103

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

278

3625

0.75

5.28

1.5

1.6

iu/ml

6.2

7.2

0.07

874

(3004451) EKG impression Narrative

132

851

1.53

5.19

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

478

1.71

5.16

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3064

32548

0.91

5.12

3.6

3.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

281

2082

1.33

5.12

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

406

3161

1.27

5.10

1.2

—

(3019977) pH of Arterial blood

146

966

1.49

5.09

3.2

2.5

7.4

1.43

345

(3000494) Fungus identified in Specimen by Culture

1762

15594

1.12

5.01

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

310

2343

1.31

4.92

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.22

4.88

1.1

u/field

1.1

0.9

0.75

(3036782) Glucose [Moles/volume] in Pleural fluid

239

1742

1.36

4.87

1.3

1.4

mmol/l

6.3

0.06

222

1601

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

122

785

1.53

4.87

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

122

785

1.53

4.87

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

122

785

1.53

4.87

1.7

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

226

1637

1.36

4.80

2.5

3.5

61.7

59.2

0.77

126

1049

(3044941) Cell count panel - Synovial fluid

173

2389

0.71

4.80

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

216

1555

1.37

4.77

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

414

3260

1.26

4.76

2.9

3.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

605

1.60

4.70

1.4

2.2

2.8

0.32

498

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

785

1.52

4.67

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

198

1414

1.38

4.61

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1059

11878

0.87

4.59

2.1

2.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

110

703

1.54

4.56

1.4

55.6

65.3

1.94

566

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

139

1972

0.69

4.53

1.6

1.5

64.2

61.2

0.38

1242

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1057

11840

0.87

4.50

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

612

1.58

4.50

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

612

1.58

4.50

1.7

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

620

1.57

4.49

1.7

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

140

949

1.46

4.39

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

207

1503

1.36

4.37

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

324

2510

1.28

4.31

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

207

2.00

4.31

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

243

1815

1.32

4.26

1.3

1.2

u/ml

345.7

281.9

2.16

166

1112

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

184

1317

1.38

4.26

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

184

1317

1.38

4.26

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

184

1317

1.38

4.26

1.5

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

229

1698

1.33

4.23

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1300

11429

1.13

4.16

2.5

2.2

nmol/l

403.3

377.1

4.42

1206

10379

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

338

2649

1.26

4.11

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

125

841

1.47

4.10

2.1

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

121

809

1.48

4.10

2.8

1.9

—

(3021374) Sirolimus [Mass/volume] in Blood

7.88

4.01

13.6

6.3

ug/l

7.4

8.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

487

0.42

4.00

1.6

1.8

ug/l

19.9

300.2

1.22

451

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

257

1954

1.30

3.99

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

211

2736

0.76

3.96

1.6

iu/l

5.8

4.4

0.55

841

(3017569) Oxygen content in Arterial blood

118

791

1.47

3.96

2.9

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

533

6227

0.84

3.93

1.1

1.2

iu/ml

143.7

128.3

0.36

174

2145

(3005719) IgG [Mass/volume] in Serum or Plasma

1088

9496

1.14

3.92

2.5

2.8

g/l

10.6

10.7

0.27

972

8640

(3037556) Urate [Mass/volume] in Serum or Plasma

495

0.44

3.90

1.3

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

119

802

1.46

3.89

1.4

umol/l

13.9

14.2

0.18

112

749

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1114

0.63

3.85

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

127

869

1.44

3.84

1.2

1.3

u/l

175.1

92.3

1.66

110

747

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

1517

0.68

3.84

1.5

1.4

e6/l

54566.1

151354.7

2.83

1034

(3044290) Cell count panel - Cerebral spinal fluid

180

2375

0.74

3.83

1.3

—

(3021901) Oxygen saturation in Capillary blood

397

3202

1.23

3.76

2.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

254

3187

0.78

3.73

1.5

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

848

0.58

3.73

1.2

1.4

pmol/l

86.3

97.8

0.11

269

(46235355) HIV 1 and 2 tests - Meaningful Use set

1462

13036

1.11

3.69

1.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

693

0.54

3.67

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

152

2.07

3.67

1.8

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

101

1455

0.68

3.66

1.5

27.1

27.8

0.07

907

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

2129

1.27

3.63

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

123

847

1.43

3.62

1.2

1.3

u/l

46.1

26.0

1.85

104

711

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

196

2530

0.76

3.60

1.1

1.2

u/ml

3.6

5.4

0.40

196

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.41

3.58

1.3

2.7

pmol/l

1.9

59.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

129

899

1.42

3.56

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3527

32760

1.07

3.54

1.8

1.7

pmol/l

12487475.5

28085796.2

1.56

2891

26334

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

563

1.52

3.51

2.7

2.6

—

31.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

862

7470

1.14

3.50

1.8

1.9

g/l

1.4

0.03

775

6694

(3034860) Kappa light chains.free [Mass/volume] in Serum

499

5794

0.84

3.47

2.6

3.2

mg/l

68.4

69.8

0.03

407

4657

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

484

5629

0.84

3.44

2.6

3.2

ratio

1.8

3.6

1.91

406

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

499

5784

0.84

3.41

2.6

3.2

mg/l

38.2

48.9

2.20

408

4649

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

124

866

1.41

3.41

1.7

2.0

u/field

2.6

2.4

0.12

591

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

442

1.58

3.40

1.9

1.8

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

538

1.52

3.34

1.4

25.8

19.8

1.12

475

(3041096) Erythrocytes [Presence] in Urine by Automated

3674

34242

1.07

3.33

4.3

3.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

555

0.51

3.32

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2312

21189

1.09

3.28

1.5

g/l

2.8

2.7

1.62

1367

12136

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

439

1.57

3.27

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

340

1.65

3.25

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

235

1820

1.27

3.24

1.3

u/l

585.9

437.8

0.22

219

1723

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

8.44

3.23

1.2

1.0

umol/l

56.0

19.0

—

(3035880) pH of Pleural fluid

148

1077

1.36

3.20

1.2

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1321

0.69

3.18

1.8

2.1

titre

1.8

2.6

—

(44813793)

699

0.58

3.18

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

130

928

1.38

3.17

2.4

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

229

1774

1.27

3.17

2.7

3.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

127

1709

0.73

3.16

1.9

1.8

—

(3015736) pH of Urine

5112

52425

0.94

3.11

3.8

3.7

5.9

5.7

0.75

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

492

1.52

3.10

1.6

nmol/l

6.4

5.2

0.24

419

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1044

0.66

3.09

1.0

u/ml

1.8

1.0

0.46

421

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1231

0.69

3.08

1.1

u/ml

3.8

1.4

0.44

484

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

490

5630

0.85

3.05

2.1

2.5

g/l

0.8

1.1

1.26

416

4698

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

550

1.49

3.04

2.5

2.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

1329

0.70

3.01

1.5

1.6

u/ml

31.1

26.4

0.38

299

(44806118)

203

1561

1.28

3.00

1.4

—

(44790047)

203

1562

1.28

2.99

1.4

—

(44790049)

203

1562

1.28

2.99

1.4

—

(44790048)

203

1562

1.28

2.99

1.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.74

2.98

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

2691

0.79

2.98

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

544

6186

0.86

2.97

2.2

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

181

1374

1.30

2.96

1.9

2.3

u/field

2.6

2.1

0.55

529

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

333

2714

1.21

2.93

1.1

u/ml

5.0

10.3

1.58

230

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

123

883

1.37

2.93

1.9

14.7

15.8

0.28

344

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

209

2597

0.79

2.92

1.1

—

(3022689) Creatine [Moles/volume] in Urine

426

0.48

2.91

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1155

0.69

2.87

1.1

—

15.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

540

0.55

2.86

1.1

1.2

g/l

39.7

0.00

272

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

462

1.51

2.86

2.0

1.7

u/ml

56234.1

45796.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

990

0.66

2.86

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

511

1.49

2.83

1.7

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

962

0.66

2.80

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

249

1.70

2.79

1.2

1.3

mmol/l

1.5

1.1

0.28

158

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.46

2.77

1.8

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

136

1771

0.75

2.76

1.4

1.5

—

(3024263) Appearance of Synovial fluid

815

0.64

2.75

1.5

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1074

0.69

2.74

1.0

u/ml

7.2

3.6

0.58

483

(21494814) CD8 cells/100 lymphocytes in Specimen

515

1.47

2.74

1.9

1.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

124

903

1.35

2.73

1.9

72.6

70.3

0.83

119

854

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

200

1.77

2.70

1.7

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

603

0.59

2.67

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

470

1.49

2.66

1.2

1.4

23.3

21.8

0.17

392

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

238

1.70

2.65

1.2

1.3

u/l

66.8

348.6

0.79

170

(3026470) Cobalt [Mass/volume] in Blood

1159

0.70

2.65

1.8

1.9

ug/l

3.9

3.7

0.07

1018

(3045142) Bone marrow Pathology biopsy report

217

1712

1.25

2.64

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1341

0.73

2.63

1.1

1.2

mmol/l

7.5

7.8

0.50

933

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

436

0.52

2.63

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1167

0.71

2.61

1.4

1.8

titre

2586.7

2427.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

898

0.67

2.59

1.0

1.1

—

38.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

510

0.56

2.59

1.1

ng/l

87.4

446.1

—

138

(3025577) Chromium [Mass/volume] in Blood

1130

0.70

2.58

1.9

2.0

ug/l

2.2

0.01

935

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

557

6248

0.87

2.56

2.0

2.3

g/l

10.4

10.3

0.07

462

5134

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1127

0.71

2.55

1.2

1.3

titre

98.3

447.7

—

115

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

454

5155

0.86

2.49

2.1

2.2

g/l

36.5

37.2

1.43

378

4325

(3032352) Blasts [#/volume] in Cerebral spinal fluid

134

1.91

2.48

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

1562

0.75

2.47

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13448

130651

1.06

2.47

31.1

16.6

mg/l

37.4

26.4

206.27

12544

106495

(40761535) Cells panel - Urine sediment

1211

12975

0.91

2.46

3.4

3.6

—

(3014271) Vancomycin [Susceptibility]

144

1093

1.30

2.43

2.8

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

481

5424

0.87

2.41

1.6

1.8

u/l

38.6

38.5

0.03

422

4626

(3034274) Bile acid [Moles/volume] in Serum --fasting

555

1.42

2.39

2.2

1.4

umol/l

40.4

8.7

1.88

390

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

393

4492

0.86

2.37

2.2

2.3

g/l

0.0

0.00

356

4090

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

201

1596

1.24

2.35

1.4

1.3

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

1235

0.73

2.35

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

599

1.40

2.34

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

337

2817

1.18

2.33

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

295

3446

0.84

2.33

1.6

1.9

mg/l

12.2

11.9

0.16

269

3169

(3006442) Creatine [Moles/volume] in Serum or Plasma

120

894

1.32

2.33

1.5

1.7

umol/l

69.9

72.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2559

23852

1.07

2.30

1.2

u/ml

2.2

1.8

0.58

627

5941

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

637

0.63

2.29

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

296

1.56

2.26

1.5

1.4

11.8

9.4

0.22

148

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

309

3584

0.85

2.26

1.3

1.5

g/l

0.2

0.23

288

3368

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1100

0.72

2.25

1.1

—

73.9

—

(3011412) CD3 cells [#/volume] in Blood

151

1167

1.28

2.24

2.1

2.2

e9/l

1.1

0.20

103

718

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

717

0.66

2.24

1.2

1.1

mg/l

54.4

44.4

0.57

607

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

228

1.64

2.22

1.3

1.4

76.3

72.5

0.39

189

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

320

3695

0.85

2.22

1.4

1.5

g/l

1.2

0.19

301

3483

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

761

0.67

2.20

1.3

u/ml

0.2

1.3

3.98

406

(1001926) Buprenorphine [Presence] in Urine by Screen method

1049

0.72

2.19

1.5

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

148

1146

1.27

2.18

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

384

4363

0.86

2.17

2.4

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

432

3708

1.15

2.15

1.4

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

356

0.52

2.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

356

0.52

2.15

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

356

0.52

2.15

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

356

0.52

2.15

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

402

4543

0.87

2.12

1.1

u/ml

2.1

10.1

0.70

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

578

1.38

2.11

1.2

1.3

ug/l

763.3

219.9

0.93

306

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

106

1365

0.76

2.08

1.8

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3075

28915

1.06

2.06

1.7

mg/l

2.2

1.4

14.46

2518

22495

(3037756) Immunofixation for Serum or Plasma

336

3836

0.86

2.05

1.5

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

737

0.68

2.05

1.1

nmol/l

2.8

8.0

0.93

156

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

606

6654

0.89

2.05

2.0

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

128

1604

0.78

2.04

1.2

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

599

1.37

2.03

1.2

1.3

mmol/l

3.7

3.5

0.25

545

(3000060) B lymphocytes [#/volume] in Blood

242

1.59

2.03

1.7

1.9

e6/l

2372.8

940.8

0.43

127

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

607

6660

0.89

2.02

2.0

2.3

g/l

7.6

7.4

1.75

438

4825

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

605

6639

0.89

2.02

2.0

2.3

g/l

3.8

0.21

419

4638

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.45

2.02

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

129

993

1.28

2.02

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

377

1.46

2.01

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

585

6429

0.89

2.01

1.4

1.5

u/ml

16.6

17.9

0.05

150

(3047189) Immunofixation for 24 hour Urine

836

0.71

1.98

1.5

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

275

1.54

1.97

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

206

1677

1.21

1.96

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

407

4567

0.87

1.96

2.2

2.3

g/l

0.0

0.60

359

4103

(21494815) CD4 cells/100 lymphocytes in Specimen

131

1016

1.27

1.94

2.1

2.0

37.2

39.7

0.25

121

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

352

3008

1.15

1.91

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

490

4284

1.13

1.89

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

281

3229

0.85

1.89

2.4

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

907

0.73

1.88

1.0

u/ml

1.9

1.8

0.02

208

(3009542) Hematocrit [Volume Fraction] of Blood

11312

112936

0.96

1.88

32.7

18.0

36.4

38.9

111.21

7180

71271

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.32

1.88

1.7

1.5

mg/l

0.3

1.4

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.32

1.88

1.7

1.5

mg/l

0.1

1.7

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.32

1.88

1.7

1.5

mg/l

1.0

1.9

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.32

1.88

1.7

1.5

mg/l

0.2

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

221

1822

1.20

1.86

1.4

1.3

nmol/l

0.7

2.2

1.04

207

1742

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1085

0.75

1.85

1.2

1.3

titre

110.0

62.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

517

1.37

1.84

2.8

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

517

1.37

1.84

2.8

2.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.02

1.83

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

590

0.67

1.82

3.7

5.0

u/ml

45.4

482.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

647

5764

1.11

1.81

2.1

2.3

ug/l

492.0

631.2

0.43

621

5427

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

809

0.72

1.81

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

595

1.34

1.81

5.1

6.5

mmol/l

25.0

24.8

0.13

535

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

808

0.72

1.79

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

785

0.71

1.79

1.0

u/ml

5.2

2.9

0.43

304

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

396

0.60

1.79

1.1

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

564

6163

0.90

1.79

2.1

2.3

g/l

3.2

3.1

2.16

427

4720

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

807

0.72

1.78

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

504

0.64

1.78

1.1

u/l

2.1

1.1

0.52

251

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

503

0.65

1.76

1.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

110

1373

0.79

1.75

1.4

1.7

—

(3036603) Volume of Urine

122

953

1.26

1.74

1.7

1.6

1743.5

1945.6

1.02

244

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

803

0.72

1.74

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

803

0.72

1.74

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

220

1827

1.19

1.73

1.4

1.3

nmol/l

0.2

0.3

0.98

153

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

100

1261

0.78

1.73

1.7

1.8

mg/l

4.2

4.4

0.20

1182

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

676

0.70

1.73

1.1

mg/l

399.0

308.4

0.77

596

(3016879) Cocaine [Presence] in Urine

101

1271

0.78

1.72

1.4

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

317

0.56

1.72

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

801

0.72

1.72

1.1

—

(40762814) Titanium [Mass/volume] in Blood

329

0.57

1.71

2.2

ug/l

3.3

3.5

—

113

(3029937) Albumin [Presence] in Urine by Test strip

3873

36803

1.05

1.71

4.3

4.4

estimate

0.0

0.34

1375

11607

(3027008) Opiates [Presence] in Urine

110

1368

0.79

1.70

1.4

1.7

—

(3023410) Appearance of Cerebral spinal fluid

1103

0.77

1.70

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

168

1.64

1.70

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

441

4869

0.89

1.69

2.2

2.3

g/l

0.1

0.0

0.25

393

4384

(3006270) Folate [Moles/volume] in Blood

169

1373

1.21

1.69

1.2

nmol/l

343.1

329.5

0.34

133

1067

(3009343) pH of Capillary blood

1129

10353

1.08

1.68

3.6

3.7

7.4

0.18

140

1370

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1091

9993

1.08

1.68

3.6

3.7

mmol/l

1.9

1.8

0.15

782

7390

(3034891) Synovial lining cells/100 cells in Synovial fluid

717

0.71

1.67

1.4

1.5

2.6

3.5

0.34

160

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

198

2313

0.84

1.67

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

171

1395

1.21

1.65

3.0

mg/l

43.5

44.7

0.03

122

1029

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.26

1.64

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

155

1.65

1.63

1.9

3.5

ng/l

85.5

158.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

114

892

1.26

1.63

1.2

mmol/l

11.6

12.1

0.24

274

(3000764) Benzodiazepines [Presence] in Urine

110

1359

0.80

1.63

1.4

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.15

1.61

8.2

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.15

1.61

4.1

3.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

156

1855

0.83

1.61

2.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

176

1447

1.20

1.58

1.3

u/l

13.5

13.4

0.03

156

1338

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5433

54886

0.96

1.58

2.4

2.2

nmol/l

74.6

79.3

27.34

4888

47757

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

143

1155

1.22

1.55

1.0

1.1

u/ml

6.3

3.9

0.51

400

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

115

1403

0.81

1.54

1.1

au/ml

10.8

11.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1138

10481

1.07

1.53

3.6

3.7

kpa

5.1

3.26

1046

9615

(3024139) IgG subclass 3 [Mass/volume] in Serum

150

1220

1.21

1.52

1.3

1.4

g/l

0.4

0.06

842

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

1220

1.21

1.52

1.3

1.4

g/l

3.0

2.9

0.10

837

(3027135) IgG subclass 1 [Mass/volume] in Serum

150

1222

1.21

1.50

1.3

1.4

g/l

6.7

7.1

0.62

838

(4024509)

123

1485

0.81

1.50

1.7

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

159

1.61

1.50

1.1

1.0

—

(4027681)

505

0.68

1.48

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

127

0.39

1.48

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

277

0.57

1.48

2.6

2.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

631

0.72

1.47

1.0

u/ml

1.4

0.3

—

167

(3015235) Bicarbonate [Moles/volume] in Capillary blood

491

4371

1.11

1.46

3.1

mmol/l

24.1

24.8

2.45

425

3847

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

592

1.30

1.45

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

108

1316

0.81

1.45

1.2

—

(3027944) Amphetamines [Presence] in Urine

110

1336

0.81

1.43

1.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

101

794

1.25

1.42

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

101

794

1.25

1.42

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

874

0.76

1.42

1.7

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

807

0.76

1.42

1.1

—

(3016038) Potassium [Moles/volume] in Urine

128

1034

1.22

1.41

1.3

1.1

mmol/l

36.6

34.6

0.43

116

855

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

760

1.26

1.41

1.1

u/l

102.4

89.2

0.59

574

(3028679) Herpes simplex virus Ab [Presence] in Serum

464

0.68

1.40

1.2

1.1

—

(4062490)

149

1223

1.20

1.40

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

1386

0.82

1.40

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

221

0.53

1.38

2.8

2.9

mg/l

8.9

6.8

—

179

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.94

1.37

1.0

8.5

8.2

0.13

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.94

1.37

1.0

1.1

20.8

21.0

0.06

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.94

1.37

1.0

1.1

35.8

37.6

0.86

(3040151) Glucose [Moles/volume] in Capillary blood

229

1953

1.16

1.37

8.7

11.0

mmol/l

7.4

7.5

0.16

198

1601

(3017704) Immunofixation for Urine

979

0.78

1.37

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

206

1744

1.16

1.36

1.1

iu/ml

5271.1

7137.5

0.08

340

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

643

1.27

1.34

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.82

1.33

1.6

1.4

mmol/l

22.8

23.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

212

1.49

1.33

2.5

3.0

u/field

0.8

0.4

1.42

212

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.04

1.33

1.6

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

572

0.72

1.32

1.2

1.1

ratio

1.1

0.02

195

(3028707) Methadone [Presence] in Urine by Screen method

651

0.74

1.31

1.7

2.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

759

1.25

1.31

1.1

u/l

44.8

26.4

1.37

548

(3042631) Mycobacterium sp identified in Specimen

280

2431

1.14

1.31

2.3

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

649

6913

0.92

1.29

3.1

3.2

pmol/l

4.2

4.4

3.00

569

6036

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

312

0.63

1.26

1.9

2.4

nmol/l

147.3

136.3

0.17

275

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

233

1.44

1.22

1.6

1.8

ug/l

2.5

7.0

0.81

145

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.97

1.22

1.1

nmol/l

227.1

269.4

0.52

(40768793) Breast Pathology biopsy report

206

2327

0.87

1.22

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

742

0.77

1.21

1.9

1.5

u/l

8.3

6.1

0.35

612

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

292

1.38

1.20

1.1

1.2

umol/l

2.0

2.8

2.01

269

(3001964) Herpes simplex virus Ag [Presence] in Specimen

368

1.34

1.19

1.4

—

(3022725) Serotonin [Moles/volume] in Serum

2.13

1.19

1.6

1.5

nmol/l

2744.4

809.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.13

1.19

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.59

1.19

4.0

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

389

0.68

1.19

1.0

1.1

miu/ml

1495.3

1567.1

0.12

389

(21491868) Cryoglobulin [Mass/volume] in Serum

467

0.72

1.15

1.2

g/l

—

0.4

—

(3051101) Glucose [Moles/volume] in Cord blood

328

0.66

1.15

5.7

6.1

—

(3035350) Ketones [Presence] in Urine by Test strip

6635

66502

0.97

1.15

4.1

4.0

estimate

0.0

0.50

1532

12156

(3048879) Bone marrow aspiration report

533

0.74

1.13

1.7

1.6

—

(36303858) Crystals [Presence] in Urine

2.46

1.13

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.46

1.13

4.0

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

467

5002

0.92

1.10

1.6

titre

148.8

251.6

1.26

232

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

752

0.78

1.10

2.2

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.70

1.09

1.3

1.2

—

(3001729) Color of Synovial fluid

138

0.50

1.08

1.1

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

160

0.55

1.08

1.0

1.2

—

98.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

209

2331

0.88

1.06

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

10447

103940

0.97

1.03

40.1

20.1

14.8

13.9

307.65

10288

101424

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

146

0.54

1.03

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

105

1230

0.84

1.03

1.1

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

174

0.57

1.00

1.1

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

108

0.46

1.00

1.0

—

6.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

374

0.71

0.99

1.1

—

(3008295) Osmolality of Serum or Plasma

168

1444

1.15

0.98

1.2

1.3

mosm/kgh2o

276.0

277.5

0.39

135

1082

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

3.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

382

1.29

0.97

2.0

1.9

14.0

11.3

0.46

340

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

128

1080

1.17

0.96

1.1

95.8

94.8

0.18

114

1000

(3023430) Cat dander IgE Ab [Units/volume] in Serum

726

0.80

0.96

1.0

u/ml

4.4

2.7

0.46

283

(46236302) HLA-C [Type] by High resolution typing

1.91

0.95

1.0

—

(40760410) HLA-B [Type] by High resolution

1.91

0.95

1.0

—

(40760409) HLA-A [Type] by High resolution

1.91

0.95

1.0

—

(40763590) HLA-DQ beta [Type]

1.91

0.95

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.77

0.94

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1080

0.84

0.94

1.1

1.2

u/ml

36.0

41.4

—

(3051593) INR in Capillary blood by Coagulation assay

961

0.83

0.93

14.8

11.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

281

1.33

0.93

2.0

1.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.82

0.92

1.7

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

2.11

0.90

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

578

0.78

0.90

1.0

1.1

iu/ml

9.1

11.1

—

124

(3009871) Measles virus Ab [Titer] in Serum

286

0.69

0.90

1.6

1.7

—

(3022621) pH of Urine by Test strip

912

9452

0.95

0.89

3.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

319

0.71

0.88

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

125

0.55

0.88

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

153

0.58

0.88

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

117

1.51

0.88

1.9

1.8

mmol/l

1.3

1.1

0.09

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

307

0.70

0.87

1.5

1.6

ng/l

162.5

126.1

0.42

307

(3041918) Cholesterol [Moles/volume] in Pleural fluid

345

1.28

0.87

1.2

mmol/l

1.5

0.09

216

(3028433) Virus identified in Specimen by Culture

459

1.24

0.87

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

158

1.43

0.87

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3859

37139

1.03

0.86

1.7

1.6

nmol/l

20.5

20.0

1.00

3402

31420

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

551

0.79

0.85

1.2

1.3

45.4

59.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

386

3509

1.08

0.85

1.7

—

(3007733) Chloride [Moles/volume] in Urine

1.91

0.83

1.2

1.1

mmol/l

87.3

88.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

269

0.69

0.82

1.9

1.8

mmol/l

1.2

0.56

263

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

113

0.52

0.82

1.2

1.1

—

(3022313) Gas panel - Capillary blood

796

7438

1.06

0.79

3.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

392

4155

0.93

0.79

1.4

iu/ml

20.5

14.7

0.26

(3000285) Sodium [Moles/volume] in Blood

220

0.67

0.79

1.1

—

(3025130) Human papilloma virus identified in Specimen

814

0.83

0.79

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

147

0.60

0.78

1.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

1676

0.89

0.78

1.3

pmol/l

294.7

283.2

0.12

111

1259

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.51

0.78

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

299

1.28

0.77

1.0

1.2

78.8

82.9

0.20

158

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

121

0.57

0.77

1.7

1.9

umol/l

20.3

17.6

—

121

(3009261) Glucose [Presence] in Urine by Test strip

6748

67333

0.98

0.77

4.2

4.0

estimate

0.0

2.35

1522

11955

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

188

1.36

0.76

1.2

ug/l

41.5

113.7

8.53

119

(3016330) Potassium [Moles/time] in 24 hour Urine

171

0.63

0.76

1.1

1.2

—

89.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

431

0.78

0.75

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

380

1.24

0.75

6.4

8.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

153

1691

0.89

0.75

1.2

miu/ml

164.7

212.5

0.73

583

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

240

0.70

0.74

1.4

1.1

—

(40758358) Immune stain study

1.67

0.74

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

171

1508

1.12

0.73

1.2

u/ml

2.5

4.0

3.80

655

(4015189)

484

0.79

0.73

1.7

2.2

—

(3012565) Volume of 24 hour Urine

751

1.17

0.73

1.8

2.2

1681.5

1867.6

1.31

635

(3013862) HLA-DP [Type]

1.81

0.73

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

632

5888

1.06

0.72

2.4

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

157

0.63

0.72

1.4

1.1

—

(3002619) Bacteria identified in Specimen by Culture

294

1.27

0.72

1.3

—

(3049717) Cytology report of Urine Cyto stain

709

7342

0.95

0.72

2.9

2.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

361

0.76

0.71

1.1

1.0

u/ml

1.2

—

107

(44806420)

535

1.20

0.71

2.5

2.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.62

0.71

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

169

1850

0.90

0.71

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

6667

66475

0.98

0.70

5.6

5.3

estimate

0.0

0.34

1546

12304

(3006184) Hemoglobin [Mass/volume] in Capillary blood

413

3800

1.07

0.70

2.4

2.2

g/l

119.8

127.7

8.05

300

2761

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

271

0.73

0.70

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.89

0.69

1.2

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

326

0.75

0.69

1.4

1.6

ug/l

0.4

0.08

200

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

236

0.71

0.69

1.1

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

100

1.48

0.68

1.1

ug/l

98.8

81.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

118

0.58

0.67

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

456

0.80

0.67

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

345

0.77

0.65

1.1

1.0

u/ml

1.1

0.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.60

0.65

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

199

0.69

0.65

1.4

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

833

1.15

0.65

2.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.57

0.64

1.1

1.3

1.4

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

409

0.79

0.64

1.1

94.5

97.9

0.25

317

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.51

0.61

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

173

0.68

0.61

1.2

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

6.5

—

0.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.60

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3016750) Collection duration of Urine

110

960

1.13

0.60

2.0

2.1

min

491.9

500.3

0.31

686

(3020491) Glucose [Moles/volume] in Blood

1020

0.88

0.60

1.8

2.1

mmol/l

8.0

7.1

1.34

687

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

214

1936

1.09

0.59

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

219

2337

0.92

0.58

1.8

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

261

0.75

0.58

1.4

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

261

0.75

0.58

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.74

0.58

1.0

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

304

1.23

0.58

1.2

1.1

—

(3000492) Spirometry study

1070

10906

0.96

0.58

1.4

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.49

0.57

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

315

0.78

0.57

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.57

0.56

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

217

1.27

0.55

1.1

1.2

85.4

70.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

122

1.37

0.55

1.3

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

486

0.83

0.55

2.3

2.9

umol/l

31.3

28.8

0.82

364

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.42

0.55

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

726

1.14

0.55

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.60

0.54

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

174

1.30

0.54

2.0

2.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

148

1324

1.10

0.54

1.3

—

37.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

736

1.14

0.54

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.44

0.54

1.1

1.3

u/field

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

145

0.68

0.54

1.3

—

698.4

—

(3011985) Renin [Units/volume] in Plasma

166

1784

0.91

0.53

1.3

1.4

mu/l

86.5

58.8

0.52

145

1577

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

905

0.88

0.53

3.9

3.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

144

0.68

0.52

1.3

1.1

mg/g

13.4

8.7

—

136

(4212803)

166

0.71

0.51

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

337

1.20

0.50

2.2

2.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

172

1838

0.92

0.50

1.5

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

170

1539

1.09

0.50

1.2

u/ml

3.8

4.0

0.04

509

(3000330) Specific gravity of Urine by Test strip

841

7988

1.04

0.49

5.1

3.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

817

1.12

0.49

2.2

ug/min

49.4

137.2

1.87

197

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

724

1.13

0.49

2.7

2.6

33.7

36.7

0.50

247

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

242

0.77

0.48

1.4

1.9

mg/l

10.1

9.0

0.36

191

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

258

1.22

0.48

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

174

0.74

0.46

1.1

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

229

0.77

0.46

1.3

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

179

1.26

0.46

1.1

1.2

nmol/l

8.9

178532.2

0.72

149

(40757494) Bilirubin.total [Moles/volume] in Blood

863

0.89

0.46

2.5

2.1

umol/l

99.2

17.2

1.47

(3025018) Bordetella pertussis Ab [Titer] in Serum

507

0.85

0.45

1.2

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.62

0.45

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

411

0.84

0.45

1.3

32.2

32.0

0.01

263

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

306

1.19

0.44

1.0

1.1

82.6

83.6

0.05

158

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

871

1.11

0.44

2.2

2.3

e6/l

497.4

592.7

0.81

355

(3029396) Erythrocyte agglutination [Presence] in Blood

1.45

0.44

1.4

1.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

190

1.24

0.43

1.0

1.1

—

(4268621)

113

1014

1.10

0.42

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

344

0.83

0.42

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

1.27

0.42

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

272

2527

1.06

0.42

3.0

3.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

538

1.13

0.42

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

322

0.82

0.41

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

218

1.22

0.41

1.0

1.2

82.6

77.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

336

1.17

0.41

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

124.1

—

(3014891) Appearance of Pleural fluid

309

1.18

0.40

1.7

1.5

—

(21494434) Karyotype in Bone marrow

134

1429

0.92

0.40

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

355

1.16

0.40

2.8

2.6

mmol/l

8.0

7.7

0.20

227

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

180

0.77

0.40

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

130

1.29

0.40

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

320

0.83

0.39

1.5

1.4

—

(3034426) Prothrombin time (PT)

356

1.16

0.39

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

265

1.19

0.39

1.3

38.4

22.6

1.45

206

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

488

0.87

0.39

1.1

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

166

1.25

0.39

1.0

1.1

iu/ml

7.7

20.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.41

0.38

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

211

1.21

0.38

1.1

1.2

ng/l

86.1

536.7

0.63

143

(3012898) Urea [Moles/volume] in Urine

131

1.28

0.38

1.2

1.3

mmol/l

206.7

153.9

—

111

(3023419) Bacteria identified in Sputum by Culture

198

2074

0.94

0.38

2.6

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

321

1.17

0.37

6.6

8.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

154

1412

1.07

0.37

1.1

112.3

115.8

0.72

139

1257

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

338

0.84

0.36

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

856

8664

0.97

0.36

1.2

—

(3015183) Erythrocyte sedimentation rate

368

1.15

0.36

1.2

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

464

0.87

0.36

3.5

5.2

64.6

70.7

0.55

374

(3004775) Volume in Urine collected for unspecified duration

150

1377

1.07

0.35

2.0

2.2

709.1

666.0

0.48

896

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

780

1.10

0.35

2.1

2.2

e6/l

504.4

508.0

0.02

661

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.65

0.35

1.4

1.7

mg/l

0.8

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1567

15123

1.02

0.35

2.2

2.5

ug/l

4.8

7.2

9.57

1317

12882

(40763791) Oxygen content in Venous blood by calculation

1.41

0.35

8.2

4.3

ml/dl

11.6

11.4

—

(3050794) Legionella sp Ab [Presence] in Serum

120

0.74

0.35

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

565

1.12

0.35

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

534

5076

1.04

0.34

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.37

0.34

9.0

11.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.37

0.34

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

736

1.10

0.33

2.0

1.9

nmol/l

15.7

15.8

0.08

676

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

131

1383

0.93

0.33

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

211

2193

0.95

0.33

1.3

1.4

u/l

16.1

10.6

4.06

162

1756

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

316

1.15

0.33

1.1

1.2

pmol/l

315.9

266.3

0.33

222

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.31

0.32

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

344

0.86

0.32

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

393

4020

0.96

0.32

3.1

nmol/l

0.8

0.59

305

3084

(3023323) Follitropin [Units/volume] in Serum or Plasma

203

2110

0.95

0.32

1.3

iu/l

39.1

33.5

1.16

168

1803

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

294

3026

0.96

0.32

1.1

1.2

titre

172.0

161.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.32

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

655

0.90

0.32

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

427

0.88

0.32

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

144

1.23

0.31

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

144

1.23

0.31

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

144

1.23

0.31

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

205

0.82

0.31

2.2

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

319

3272

0.96

0.31

3.6

3.7

mg/l

35.8

29.3

2.06

213

2135

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

245

1.17

0.30

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

264

1.16

0.29

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

351

0.87

0.29

1.5

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

743

1.09

0.29

2.2

2.3

e9/l

0.2

0.56

658

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

163

1697

0.94

0.29

3.8

3.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

105

0.75

0.29

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

106

0.74

0.29

2.4

3.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

339

0.87

0.28

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

669

0.91

0.28

1.2

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1172

11749

0.98

0.26

3.6

3.8

ng/l

95.4

97.3

0.28

1015

9887

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

332

1.13

0.26

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

605

1.09

0.26

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

190

0.83

0.26

1.1

1.6

—

11.8

—

(3003577) Lead [Moles/volume] in Blood

0.68

0.26

1.0

1.2

—

0.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.67

0.26

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

200

0.84

0.26

2.2

2.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

336

0.88

0.26

1.3

1.6

ug/l

12.7

9.2

1.57

336

(3000093) Morphology [Interpretation] in Blood Narrative

154

1598

0.95

0.25

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

259

1.14

0.25

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

106

979

1.07

0.25

2.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

272

0.87

0.24

1.0

1.2

—

1330.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

661

6355

1.02

0.24

4.0

4.1

mmol/l

24.7

24.8

0.46

595

5775

(44806071)

124

0.79

0.24

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

156

0.82

0.24

1.0

1.1

—

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.72

0.24

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.70

0.23

1.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

219

0.85

0.23

1.2

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

113

1.22

0.23

1.3

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.28

0.23

3.6

2.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

145

0.81

0.23

2.4

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

158

1481

1.05

0.23

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

333

0.89

0.23

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

544

1.09

0.23

1.7

1.8

umol/l

168.2

109.6

0.40

292

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

373

0.90

0.22

1.2

nmol/l

115.7

133.1

0.39

273

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.74

0.22

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.73

0.22

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

114

1.21

0.22

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

362

0.90

0.21

1.5

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.20

0.21

1.4

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

397

4017

0.97

0.21

2.4

2.3

ug/min

129.9

111.2

0.34

220

2323

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.1

—

360.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

289

0.89

0.21

1.8

mmol/l

1.2

0.12

278

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

104

0.76

0.21

1.1

—

(4146454)

190

1796

1.04

0.21

2.8

2.7

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.20

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

320

1.11

0.20

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

133.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

184

0.86

0.20

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

125

1.18

0.19

1.2

umol/24h

1.4

1.7

1.42

125

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

312

1.10

0.19

1.2

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

181

1.14

0.19

5.4

5.2

ug/min

74.7

51.3

0.75

153

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.14

0.18

1.0

1.2

—

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

255

0.89

0.18

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

238

1.12

0.18

1.0

1.6

ug/l

2.9

2.4

0.16

131

(3020630) Protein [Mass/volume] in Serum or Plasma

1452

14121

1.01

0.18

2.4

2.6

g/l

64.3

66.2

14.43

1305

12636

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

257

1.11

0.18

6.0

7.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

244

0.89

0.18

1.9

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

671

0.94

0.17

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

150

0.85

0.17

2.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.11

0.17

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

813

1.05

0.16

1.3

u/l

35.7

32.4

0.34

649

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

931

0.95

0.16

5.5

5.0

u/ml

38.4

105.7

2.28

263

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.11

0.16

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

282

0.91

0.15

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.80

0.14

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

839

8149

1.01

0.14

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

311

0.92

0.14

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5139

50796

0.99

0.14

4.5

4.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.82

0.13

1.0

1.1

—

(4306422)

153

1458

1.03

0.13

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.80

0.13

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

396

1.07

0.13

1.3

1.5

pmol/l

14.5

16.7

1.85

325

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

111

1.15

0.13

1.2

1.1

u/l

12.4

12.8

0.02

111

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

149

1.12

0.13

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

299

0.92

0.12

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

299

0.92

0.12

1.3

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

0.88

0.12

3.7

4.8

—

(40757373) Influenza virus identified in Isolate

340

1.07

0.12

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

197

1.10

0.12

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

298

0.92

0.12

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

298

0.92

0.12

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

328

0.93

0.11

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

226

1.09

0.11

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

708

1.04

0.11

2.3

2.7

u/l

217.7

212.3

0.14

701

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

141

1.12

0.11

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

265

1.08

0.11

1.1

pmol/l

5.3

11.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

246

0.92

0.11

1.3

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

377

0.94

0.10

2.6

2.7

—

(37021550) Renin [Units/volume] in Plasma --upright

285

1.07

0.10

1.0

1.2

mu/l

177.2

65.1

0.85

203

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

700

1.04

0.10

6.6

6.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1007

0.97

0.10

1.1

—

(3005033) Fetal Nuchal fold Thickness US

245

0.92

0.10

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

416

0.95

0.10

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

459

1.05

0.10

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

217

2177

0.98

0.09

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

280

2801

0.98

0.09

1.6

1.5

—

(3045716) Anion gap in Serum or Plasma

732

1.04

0.09

2.5

2.1

mmol/l

9.2

9.0

0.19

553

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.09

0.09

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

213

0.92

0.08

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

172

1.09

0.08

1.9

1.6

umol/l

48.4

46.8

0.09

172

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.05

0.08

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.05

0.08

1.0

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

303

0.94

0.08

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

202

0.93

0.08

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

202

0.93

0.08

1.1

1.0

u/ml

0.9

1.0

—

(40768446) Kidney Pathology biopsy report

453

1.04

0.07

1.3

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

188

1817

1.02

0.07

1.6

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

0.07

3.3

8.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.83

0.07

1.3

1.2

nmol/l

19.6

24.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.82

0.07

1.2

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

0.91

0.07

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

207

2004

1.02

0.07

2.2

1.7

mu/l

296.7

300.6

0.06

188

1847

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

208

2080

0.98

0.07

2.0

2.2

mg/l

37.0

26.1

0.99

555

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

120

0.90

0.07

1.5

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

455

1.04

0.06

2.0

1.8

199.1

170.3

1.39

422

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

194

1.07

0.06

1.0

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

291

1.05

0.06

1.6

ug/l

94.5

112.0

0.69

244

(3006462) Nitrate [Presence] in Urine

727

0.97

0.05

4.2

3.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

139

0.92

0.05

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

149

0.92

0.05

11.3

11.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

278

0.96

0.05

1.1

1.2

umol/24h

0.7

0.00

124

(40758292) HTLV I+II Ab panel - Serum

167

1.06

0.04

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

475

4700

0.99

0.03

1.1

titre

229.1

195.1

0.17

110

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5083

49967

1.00

0.03

2.9

3.2

ng/l

1618.1

1813.6

2.14

4435

43289

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

745

1.02

0.03

1.4

nmol/l

0.3

0.2

0.59

529

(3003740) Influenza virus B Ag [Presence] in Specimen

101

1008

0.99

0.03

1.1

—

(3000012) Reticulocyte production index

102

991

1.01

0.03

1.2

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

146

0.94

0.03

1.6

1.7

—

(3017732) Neutrophils [#/volume] in Blood

919

9019

1.00

0.02

3.8

3.1

e9/l

4.2

4.1

0.04

692

6473

(3020191) Ethanol [Moles/volume] in Serum or Plasma

933

1.01

0.02

1.3

promille

1.0

1.2

0.81

708

(3044416) Complement C4 [Mass/volume] in Pleural fluid

101

1.07

0.02

1.3

1.2

g/l

0.1

—

(3020650) Glucose [Presence] in Urine

284

0.97

0.02

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

679

0.99

0.02

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

954

1.01

0.02

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

219

2168

0.99

0.02

1.2

—

(3025315) Body weight

125

0.94

0.01

5.2

5.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6440

63349

1.00

0.01

2.2

2.1

pmol/l

87.7

93.8

22.61

3830

33157

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

864

0.99

0.01

2.0

—

(3044889) 12 lead EKG panel

9740

95879

1.00

0.01

4.6

4.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

223

0.97

0.01

1.9

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

184

1803

1.00

0.01

1.3

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.00

0.00

4.0

4.7

—

(4198724)

233

1.01

0.00

1.4

—

(4133840)

309

0.99

0.00

1.4

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

621

1.00

0.00

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

216

1.00

0.00

1.1

1.2

—

(4211845)

781

1.00

0.00

4.0

3.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

290

0.98

0.00

1.1

1.3

mg/l

1.1

55.1

1.25

223

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

201

0.98

0.00

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.06

0.00

1.2

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

158

1.00

0.00

5.4

5.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

3.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.93

0.00

1.8

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.96

0.00

1.2

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.94

0.00

1.0

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.1

—

2.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.98

0.00

1.2

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

15.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.89

0.00

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.96

0.00

1.0

1.1

—

(3019174) dRVVT (LA screen)

0.93

0.00

1.0

1.2

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.7

—

8.9

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.96

0.00

1.9

1.2

umol/24h

561.6

333.5

—

(3036566) Thyroxine binding globulin [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

351.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS – Malignant neoplasm of digestive organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of digestive organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints